Search StatPearls

Tools](/content/account/POCFreeTrialCheck ""/index.html)

Back To Search Results

Thrombosis

Print Email Facebook LinkedIn X

Author: [Damilola Ashorobi](/content/point-of-care/30111#/ ""/index.html)Author: [Muhammad Atif Ameer](/content/point-of-care/30111#/ ""/index.html)Editor: [Roberto Fernandez](/content/point-of-care/30111#/ ""/index.html)Updated: 2/12/2024 2:11:43 AM

Introduction

Thrombosis is the formation of a blood clot within arterial or venous blood vessels, limiting the natural flow of blood. The ability of blood to flow freely in vessels relies on a complex homeostasis between blood cells, platelets, plasma proteins, coagulation factors, inflammatory factors, and the endothelial lining within the arterial and venous lumens. Imbalances in this physiologic process cause an increased risk of developing a thrombosis or a coagulopathy. In certain clinical circumstances, patients can be at increased risk of both thrombosis and bleeding (eg, disseminated intravascular coagulopathy or underlying malignancy). As such, the diagnosis and management of thromboses are complex. Thrombosis can arise in any organ system, and clinical presentations can vary depending on underlying comorbidities and provoking factors.

Management decisions take into account whether the thrombosis is venous or arterial, acute or chronic, and if it is an initial or subsequent episode. Other contributing factors are family history, smoking history, and hemodynamic stability. The use and duration of anticoagulation or antiplatelet therapy depends on a careful evaluation of these factors. Furthermore, a decision to pursue an exhaustive hypercoagulable workup to evaluate for inherited or acquired conditions that predispose to thrombosis is controversial. Evaluation should be completed in selected patients and with hematologist input.

Together, acute venous and arterial thromboses account for the most common causes of death in developed countries, with myocardial infarction (MI) and cerebrovascular accident (CVA) accounting for the highest proportion of thrombosis-associated death in the United States. [[1]](/content/point-of-care/30111#ref_18288180 ""/index.html) An understanding of the basic pathophysiology of thrombosis and provoking risk factors can aid clinicians in the diagnosis, workup, and management of this condition.

There are also many unique presentations that add complexity to diagnosis and treatment decisions, such as in acquired antiphospholipid syndrome (APS) or in heparin-induced thrombocytopenia and thrombosis (HITT). As such, many of these case- or disease-specific details and management aspects are beyond the scope of this review article. Readers are encouraged to consult additional references for further reading, including regularly updated subspecialty society guidelines (eg, American Society of Chest Physicians, American Heart Association, and American Society of Hematology). This review will focus primarily on the basic pathophysiology of venous and arterial thrombosis, including an assessment of risk factors, diagnostic workup, and management of venous and arterial thrombosis.

Etiology

Register For Free And Read The Full Article

Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.

  • Search engine and full access to all medical articles

  • 10 free questions in your specialty

  • Free CME/CE Activities

  • Free daily question in your email

  • Save favorite articles to your dashboard

  • Emails offering discounts

Select ProfessionPracticing PhysicianPhysician AssociatePharmacistRegistered NurseNurse Practitioner/ Advanced Practice Registered NurseLicensed Practical Nurse/ Licensed Vocational NurseMedical, Dental, Podiatry, and Optometry StudentsNursing StudentAllied HealthSocial WorkerDentistDietitianOther

Select Profession

  • Select Profession
  • Practicing Physician
  • Physician Associate
  • Pharmacist
  • Registered Nurse
  • Nurse Practitioner/ Advanced Practice Registered Nurse
  • Licensed Practical Nurse/ Licensed Vocational Nurse
  • Medical, Dental, Podiatry, and Optometry Students
  • Nursing Student
  • Allied Health
  • Social Worker
  • Dentist
  • Dietitian
  • Other

Select Primary SpecialtyAddiction MedicineAdolescent MedicineAdult Medical Surgical PN - Nursing StudentAdult Medical Surgical RN - Nursing StudentAdvanced Cardiovascular Life Support® (ACLS®)Advanced Diabetes ManagementAdvanced Emergency Medicine Ultrasonography® (AEMUS®)Advanced Trauma Life Support® (ATLS®)Aerospace MedicineAlabama State CME CE RequirementsAlaska State CME CE RequirementsAllergy and ImmunologyAnatomy and Physiology - Nursing StudentAnesthesiology - Adult CardiacAnesthesiology - AdvancedAnesthesiology - BasicAnesthesiology - In-TrainingAnesthesiology - PediatricArizona State CME CE RequirementsArkansas State CME CE RequirementsAudiology Praxis®Australian Medical Council - IMG (AMC CAT MCQ)Brain Injury Medicine (BIM®)Calculations - Nursing StudentCalifornia State CME CE RequirementsCardiac SurgeryCardiology - Adult Congenital Heart DiseaseCardiology - Adult EchocardiographyCardiology - Advanced Heart Failure and Transplant CardiologyCardiology - Cardiovascular Computed TomographyCardiology - Cardiovascular DiseaseCardiology - Cardiovascular Magnetic ResonanceCardiology - Clinical Cardiac ElectrophysiologyCardiology - InterventionalCardiology - NuclearCardiothoracic - Congenital SurgeryCardiothoracic SurgeryCaribbean Association of Medical Councils (CAMC)Certified Anesthesiology Assistants (CAA®)Certified Dental Assistant™ (CDA®)Certified EKG Technician (CET)Certified Healthcare Simulation Educator (CHSE®)Certified Hyperbaric Technologist (CHT)Certified Hypertension Clinician (CHC®)Certified Hypertension Specialist (CHS®)Certified in Healthcare Compliance (CHC®)Certified Medical Assistant (AAMA® CMA®)Certified Nursing Assistant (CNA®)Certified Occupational Therapy Assistant® (COTA®)Certified Registered Nurse Anesthetist (CRNA NCE® or SEE®)Certified Surgical First Assistant™ (CSFA®)Certified Surgical Technologist™ (CST®)Child Health PN - Nursing StudentChild Health RN - Nursing StudentClinical InformaticsClinical Lipid Specialists (CLS®)Clinical Nutritionist (CCN/CNS)Clinical Tropical Medicine and Travelers' Health (CTropMed®)CNS - Acute Care Clinical Nurse Specialist - Neonatal (ACCNS-N®)CNS - Acute Care Clinical Nurse Specialist - Pediatric (ACCNS-P®)CNS - Adult-Gerontology Clinical Nurse Specialist (ACCNS-AG® or AGCNS-BC™)CNS - Advanced Diabetes Management (BC-ADM®)Colon and Rectal Surgery / ColorectalColorado State CME CE RequirementsCOMLEX-USA® Level 1COMLEX-USA® Level 2COMLEX-USA® Level 3Community Health - Nursing StudentComplex General Surgical Oncology (CGSO®)COMVEX®Connecticut State CME CE RequirementsCorrectional MedicineCosmetic Surgery (ABCS®)Critical Care and Basic Rhythms - Nursing StudentCritical Care MedicineDelaware State CME CE RequirementsDental Licensure Objective Structured Clinical Examination (DLOSCE™)Dermatology - AppliedDermatology - BasicDermatology - CoreDermatology - Micrographic Dermatologic Surgery (Mohs)Dermatology - PediatricDermatopathologyDisaster MedicineDistrict of Columbia CME CE RequirementsEgyptian Medical Licensing Exam (EMLE)Elder Adult Care - Nursing StudentEmergency MedicineEmergency Medicine - Emergency Medical Services (ABEM® EMS®)Emergency Medicine - FRCEM SBAEmergency Medicine - MRCEM PrimaryEmergency Medicine - MRCEM SBA-FRCEM IntermediateEmirates Medical Residency Entrance Examination (EMREE)EMS - Advanced Emergency Medical Technician (NREMT® AEMT®)EMS - Certified Flight Paramedic (IBSC FP-C®)EMS - Community Paramedic (IBSC CP-C®)EMS - Critical Care Paramedic (IBSC CCP-C®)EMS - Emergency Medical Responder (NREMT® EMR®)EMS - Emergency Medical Technician (NREMT® EMT®)EMS - Paramedic (NREMT®)EMS - Tactical Paramedic Certification (IBSC TP-C®)EMS - Wilderness Paramedic (IBSC WP-C®)ENARM MexicoEndocrinologyEndovascular MedicineFacial Cosmetic SurgeryFacial Plastic and Reconstructive SurgeryFamily MedicineFamily Medicine - MRCGP-Applied Knowledge TestFlorida State CME CE RequirementsFundamentals - Nursing StudentGastroenterologyGeneral SurgeryGeneral Surgery - In-Training ABSITE®General Surgery Review (All Subspecialties) - MRCS Part AGenetics and Genomics - ClinicalGenetics and Genomics - GeneralGeorgia State CME CE RequirementsGeriatricsGuam State CME CE RequirementsHand SurgeryHawaii State CME CE RequirementsHealth Assessment - Nursing StudentHealthcare Administration, Leadership, and Management (HALM®)Healthcare Ethics Consultant Exam (HEC-C)HematologyHospice And Palliative MedicineIdaho State CME CE RequirementsIllinois State CME CE RequirementsIndian PG Entrance (NEET-PG)Indiana State CME CE RequirementsInfectious DiseaseIntegrated National Board Dental Examination (INBDE®)Internal MedicineInternal Medicine - Focused Practice In Hospital MedicineInternal Medicine - MRCP UK and Ireland Part 1Internal Medicine - MRCP UK and Ireland Part 2International Trauma Life Support® (ITLS®)Iowa State CME CE RequirementsKansas State CME CE RequirementsKentucky State CME CE RequirementsLab - Medical Laboratory Scientist MLS(ASCP®)Lab - Medical Laboratory Technician MLT(ASCP®)Lab - Phlebotomy Technician PBT(ASCP®) or (NPS CPT®)Lab - Technologist in Blood Banking BB(ASCP®)Lab - Technologist in Chemistry C(ASCP®)Lab - Technologist in Hematology H(ASCP®)Lab - Technologist in Microbiology M(ASCP®)Lab and Diagnostic Testing - Nursing StudentLifestyle MedicineLouisiana State CME CE RequirementsMaine State CME CE RequirementsMaryland State CME CE RequirementsMassachusetts State CME CE RequirementsMaternal Newborn PN - Nursing StudentMaternal Newborn RN - Nursing StudentMCCQE Part I (Medical Council of Canada Qualifying Examination)Medical Council Nigeria (MDCN)Medical Student Elective - AllergyMedical Student Elective - AnesthesiologyMedical Student Elective - Biostatistics and EconomicsMedical Student Elective - Cardiothoracic SurgeryMedical Student Elective - Cardiovascular DiseaseMedical Student Elective - Critical CareMedical Student Elective - DermatologyMedical Student Elective - Diagnostic RadiologyMedical Student Elective - ECG and Rhythm Strip ReviewMedical Student Elective - EndocrinologyMedical Student Elective - GastroenterologyMedical Student Elective - GeneticsMedical Student Elective - GeriatricsMedical Student Elective - HandMedical Student Elective - HematologyMedical Student Elective - Infectious DiseaseMedical Student Elective - Law, Medicine, and EthicsMedical Student Elective - NeonatologyMedical Student Elective - NephrologyMedical Student Elective - NeurosurgeryMedical Student Elective - OncologyMedical Student Elective - OphthalmologyMedical Student Elective - OrthopedicMedical Student Elective - OtolaryngologyMedical Student Elective - Pathology, Clinical LaboratoryMedical Student Elective - Pediatric CardiologyMedical Student Elective - Pediatric Critical CareMedical Student Elective - Pediatric EndocrinologyMedical Student Elective - Pediatric GastroenterologyMedical Student Elective - Pediatric Hematology & OncologyMedical Student Elective - Pediatric Infectious DiseasesMedical Student Elective - Pediatric NephrologyMedical Student Elective - Pediatric NeurologyMedical Student Elective - Pediatric PulmonologyMedical Student Elective - Pediatric SurgeryMedical Student Elective - Physical Medicine and RehabilitationMedical Student Elective - Plastic SurgeryMedical Student Elective - PulmonologyMedical Student Elective - RheumatologyMedical Student Elective - Sports MedicineMedical Student Elective - UrologyMedical Student Elective - Vascular SurgeryMental Health PN - Nursing StudentMental Health RN - Nursing StudentMetabolic and Bariatric Surgery (MBS FPD®)Michigan State CME CE RequirementsMicrobiology - Nursing StudentMinnesota State CME CE RequirementsMississippi State CME CE RequirementsMissouri State CME CE RequirementsMontana State CME CE RequirementsMultistate Pharmacy Jurisprudence Examination® (MPJE®)National Board Dental Hygienist Examination (NBDHE®)NBME® Shelf - Ambulatory CareNBME® Shelf - AnatomyNBME® Shelf - Behavioral ScienceNBME® Shelf - BiochemistryNBME® Shelf - Clinical NeurologyNBME® Shelf - Comprehensive Basic Science (CBSE®)NBME® Shelf - Comprehensive Clinical Science (CCC®)NBME® Shelf - EmbryologyNBME® Shelf - Emergency MedicineNBME® Shelf - Family MedicineNBME® Shelf - Health Systems ScienceNBME® Shelf - HistologyNBME® Shelf - Internal Medicine (Advanced Clinical Exam)NBME® Shelf - Introduction to Clinical DiagnosisNBME® Shelf - MedicineNBME® Shelf - Microbiology and ImmunologyNBME® Shelf - NeuroscienceNBME® Shelf - Obstetrics and GynecologyNBME® Shelf - PathologyNBME® Shelf - PediatricsNBME® Shelf - PharmacologyNBME® Shelf - PhysiologyNBME® Shelf - PsychiatryNBME® Shelf - SurgeryNBOME® Subject Exam / Shelf - Osteopathic Principles and PracticeNCLEX-PN® - Nursing StudentNCLEX-RN® - Nursing StudentNebraska State CME CE RequirementsNepal Medical Council Licensing Examination (NMCLE)NephrologyNeurologyNeurology - Behavioral Neurology and NeuropsychiatryNeurology - Clinical NeurophysiologyNeurology - Epilepsy MedicineNeurology - HeadacheNeurology - Neurocritical CareNeurology - Neurodevelopmental DisabilitiesNeurology - Neuromuscular MedicineNeurology - Vascular NeurologyNeurosurgeryNevada State CME CE RequirementsNew Hampshire State CME CE RequirementsNew Jersey State CME CE RequirementsNew Mexico State CME CE RequirementsNew York State CME CE RequirementsNorth Carolina State CME CE RequirementsNorth Dakota State CME CE RequirementsNP - Adult-Gerontology Acute Care Nurse Practitioner (AGACNP® or ACNPC-AG®)NP - Adult-Gerontology Primary Care Nurse Practitioner (AGPCNP® or AGNP®)NP - Advanced Certified Hospice and Palliative Nurse (ACHPN®)NP - Advanced Health Assessment and Diagnostic Reasoning Nurse PractitionerNP - Advanced Neurovascular Practitioner Certification (ANVP-BC®)NP - Advanced Oncology Certified Nurse Practitioner (AOCNP®)NP - Advanced Pathophysiology Nurse PractitionerNP - Advanced Pharmacology Nurse PractitionerNP - Advanced Physiology Nurse PractitionerNP - Biostatistics and Epidemiology Nurse PractitionerNP - Board Certified Advanced Diabetes Management (BC-ADM®)NP - Cardiovascular Nurse Practitioner (CVNP-BC®)NP - Certified Addictions Registered Nurse - Advanced Practice (CARN-AP®)NP - Certified Continence Care Nurse - Advanced Practice (CCCN-AP®)NP - Certified Midwife (CNM®/CM®)NP - Certified Nephrology Nurse - Nurse Practitioner™ (CNN-NP™)NP - Certified Ostomy Care Nurse - Advanced Practice (COCN-AP®)NP - Certified Pediatric Nurse Practitioner - Acute Care (CPNP-AC®)NP - Certified Pediatric Nurse Practitioner – Primary Care (CPNP-PC®)NP - Certified Urologic Nurse Practitioner (CUNP®)NP - Certified Wound Care Nurse - Advanced Practice (CWCN-AP® / AWCC™)NP - Certified Wound Ostomy Continence Nurse - Adv. Practice (CWOCN-AP®)NP - Dermatology Certified Nurse Practitioner (DCNP®)NP - Emergency Nurse Practitioner (ENP®)NP - Ethics & Legal Issues Nurse PractitionerNP - Family Nurse Practitioner (ANCC/FNP-BC™ or AANP/FNP-C®)NP - Health Promotion and Disease Prevention Nurse PractitionerNP - Neonatal Nurse Practitioner (NNP-BC®)NP - Nurse Executive Advanced Certification (NEA-BC®)NP - Orthopedic Nurse Practitioner (ONP-C®)NP - Pediatric Primary Care Mental Health Specialist (PMHS®)NP - Psychiatric-Mental Health Nurse Practitioner Certification (PMHNP-BC™)NP - Theory and Evidence-Based Practice Nurse PractitionerNP - Women's Health Nurse Practitioner (WHNP®)Nuclear MedicineNurse - Ambulatory Care Nursing Certification (AMB-BC™)Nurse - Assisted Living Nursing Certification (C-AL®)Nurse - Bariatric (CBN®)Nurse - Cardiac Medicine Certification (CMC®) AdultNurse - Cardiac-Vascular Nursing Certification (CV-BC™)Nurse - Cardiovascular Nursing (CVN®)Nurse - Case Management Certification (CMGT-BC™)Nurse - Certified Addictions Registered Nurse (CARN®)Nurse - Certified Anticoagulation Care Provider (CACP®)Nurse - Certified Breast Care Nurse (CBCN®)Nurse - Certified Clinical Transplant Nurse (CCTN®)Nurse - Certified Continence Care Nurse (CCCN®)Nurse - Certified Diabetes Care and Education Specialist® (CDCES®)Nurse - Certified Emergency Nurse® (CEN®)Nurse - Certified Flight Registered Nurse (CFRN®)Nurse - Certified Foot Care Nurse (CFCN®)Nurse - Certified Gastroenterology Registered Nurse (CGRN®)Nurse - Certified Hemodialysis Nurse (CHN®)Nurse - Certified Hospice and Palliative Nurse (CHPN®)Nurse - Certified Hyperbaric Registered Nurse® (CHRN®)Nurse - Certified Infection Control (CIC®)Nurse - Certified Managed Care Nurse (CMCN®)Nurse - Certified Nephrology Nurse (CNN®)Nurse - Certified Neuroscience Registered Nurse (CNRN®)Nurse - Certified Nurse Educator (CNE®)Nurse - Certified Nurse Manager and Leader (CNML®)Nurse - Certified Occupational Health Nurse (COHN® and COHN-S®)Nurse - Certified Ostomy Care (COCN®) / Ostomy Management Specialist (OMS®)Nurse - Certified Otorhinolaryngology Nurse (CORLN®)Nurse - Certified Pediatric Emergency Nurse (CPEN®)Nurse - Certified Pediatric Hematology Oncology Nurse (CPHON®)Nurse - Certified Pediatric Nurse (CPN®)Nurse - Certified Perioperative Nurse (CNOR®)Nurse - Certified Peritoneal Dialysis Nurse (CPDN®)Nurse - Certified Plastic Surgery Nurse (CPSN®)Nurse - Certified Post and Ambulatory Perianesthesia Nurse (CPAN® / CAPA®)Nurse - Certified Professional in Health Care Risk Management (CPHRM®)Nurse - Certified Professional in Healthcare Quality (CPHQ®)Nurse - Certified Radiology Nurse (CRN©)Nurse - Certified Registered Nurse in Ophthalmology (CRNO®)Nurse - Certified Registered Nurse Infusion (CRNI®)Nurse - Certified Rehabilitation Registered Nurse (CRRN®)Nurse - Certified Transport Registered Nurse (CTRN®)Nurse - Certified Urologic Registered Nurse (CURN®)Nurse - Certified Wound Care Nurse (CWCN® / WCC®)Nurse - Critical Care Registered Nurse - Adult (CCRN®)Nurse - Critical Care Registered Nurse - Neonatal (CCRN®)Nurse - Critical Care Registered Nurse - Pediatric (CCRN®)Nurse - Dermatology Nurse Certified (DNC®)Nurse - Emergency Nurse Pediatric Certification© (ENPC®)Nurse - Gerontology Nursing Certification (GERO-BC™)Nurse - Informatics Nursing Certification (NI-BC™)Nurse - Inpatient Obstetric Nursing (RNC-OB®)Nurse - International Board Certified Lactation Consultant® (IBCLC®)Nurse - Low Risk Neonatal Intensive Care Nursing (RNC-LRN®)Nurse - Maternal Newborn Nursing (MNN®)Nurse - Medical-Surgical Nursing Certification (MEDSURG-BC™)Nurse - Nationally Certified School Nurse (NCSN®)Nurse - Neonatal Pediatric Transport (C-NPT®)Nurse - Nurse Executive Certification (NE-BC®)Nurse - Nursing Professional Development Certification (NPD-BC™)Nurse - Oncology Certified Nurse (OCN®)Nurse - Orthopedic Nurse Certification (ONC®)Nurse - Pain Management Nursing Certification (PMGT-BC™)Nurse - Progressive Care Certified Nurse (PCCN®) - AdultNurse - Psychiatric-Mental Health Nursing Certification (PMH-BC™)Nurse - Registered Nurse First Assistant (RNFA©)Nurse - Sexual Assault Nurse Examiner (SANE®)Nurse - Stroke Certified Registered Nurse (SC-RN®)Nurse - Trauma Certified Registered Nurse (TCRN®)Nurse - Vascular Access Board Certified Nursing (VA-BC®)Nutrition - Nursing StudentNutrition MedicineObesity MedicineOb-Gyn - CREOG® In-ServiceOb-Gyn - Gynecologic OncologyOb-Gyn - Maternal-Fetal MedicineOb-Gyn - MRCOG UK and Ireland Part 1Ob-Gyn - MRCOG UK and Ireland Part 2 and Part 3Ob-Gyn - Obstetrics and GynecologyOb-Gyn - Reproductive Endocrinology and InfertilityOb-Gyn - Urogynecology and Reconstructive Pelvic SurgeryOccupational MedicineOccupational Therapist Registered (NBCOT® OTR®)Ohio State CME CE RequirementsOklahoma State CME CE RequirementsOncologyOphthalmologyOphthalmology - CataractOphthalmology - Cornea and External Eye DiseaseOphthalmology - GlaucomaOphthalmology - Medical and Surgical RetinaOphthalmology - Neuro-OphthalmologyOphthalmology - Oculoplastic SurgeryOphthalmology - OpticsOphthalmology - Pediatric and StrabismusOphthalmology - UveitisOphthamology - TraumaOptometry - Advanced Medical CareOptometry - Applied Basic Science (ABS®)Optometry - Patient Assessment and Management (PAM®)Oral And Maxillofacial SurgeryOregon State CME CE RequirementsOrthopedic SurgeryOsteopathic Neuromusculoskeletal Medicine (OMT/NMM®/OMM®)Otolaryngology - Head and Neck SurgeryPA - Cardiovascular and Thoracic Surgery (CAQ-CVTS®)PA - Cardiovascular Physician Assistant/Associate (CVPA-BC®)PA - Clinical Knowledge Rating and AssessmentPA - Dermatology (CAQ-Derm® or NBDPA™)PA - Emergency Medicine (CAQ-EM®)PA - Emergency Medicine End of RotationPA - End of CurriculumPA - Family Medicine End of RotationPA - Hospital Medicine (CAQ-HM®)PA - Internal Medicine End of RotationPA - Nephrology (CAQ-Neph®)PA - Obstetrics and Gynecology (CAQ-OBGYN®)PA - Occupational Medicine (CAQ-OM®)PA - Orthopedic (CAQ-OS®)PA - Palliative Medicine and Hospice Care (CAQ-PMHC®)PA - PANCE®PA - PANRE®PA - Pediatric (CAQ-Peds®)PA - Pediatric End of RotationPA - Psychiatric and Behavioral Health End of RotationPA - Psychiatry (CAQ-Psy®)PA - Surgery End of RotationPA - Womens Health End of Rotation (Gyn, Sexual, & Reproductive Health)Pain MedicinePakistan - 1st Professional MBBSPakistan - 2nd Professional MBBSPakistan - 3rd Professional MBBSPakistan - 4th Professional MBBSPakistan - Final Professional MBBSPakistan FCPS Part I (Basic Science)Pathology - AnatomicPathology - Blood Banking Transfusion MedicinePathology - ChemicalPathology - ClinicalPathology - CytopathologyPathology - ForensicsPathology - HematopathologyPathology - MicrobiologyPathology - Molecular GeneticPathology - NeuropathologyPathology - PediatricPathophysiology - Nursing StudentPediatricPediatric - CardiologyPediatric - Child AbusePediatric - Critical CarePediatric - Developmental BehavioralPediatric - Emergency MedicinePediatric - EndocrinologyPediatric - GastroenterologyPediatric - Hematology-OncologyPediatric - Hospital MedicinePediatric - Infectious DiseasesPediatric - MRCPCH UKPediatric - Neonatal PerinatalPediatric - NephrologyPediatric - NeurologyPediatric - PulmonologyPediatric - Rehabilitation MedicinePediatric - RheumatologyPediatric Advanced Life Support® (PALS®)Pediatric SurgeryPennsylvania State CME CE RequirementsPharmacology PN - Nursing StudentPharmacology RN - Nursing StudentPharmacy - Ambulatory Care (BCACP®)Pharmacy - Applied Toxicology (ABAT®)Pharmacy - Cardiology (BCCP®)Pharmacy - Certified Pharmacy Technician (PTCB® CPhT®)Pharmacy - Critical Care (BCCCP®)Pharmacy - Emergency Medicine (BCEMP®)Pharmacy - Geriatric (BCGP®)Pharmacy - Infectious Disease (BCIDP®)Pharmacy - NAPLEX®Pharmacy - Nutrition Support (BCNSP®)Pharmacy - Oncology (BCOP®)Pharmacy - Pediatric (BCPPS®)Pharmacy - Pharmacotherapy (BCPS®)Pharmacy - Psychiatric (BCPP®)Physical Medicine and RehabilitationPhysical Therapy - Geriatric Clinical Specialist (ABPTS® APTA® GCS)Physical Therapy - Neurology Clinical Specialist (ABPTS® APTA® NCS)Physical Therapy - Orthopedic Clinical Specialist (ABPTS® APTA® OCS)Physical Therapy - Pediatric Clinical Specialist (ABPTS® APTA® PCS)Physical Therapy - Physical Therapist (NPTE-PT)®Physical Therapy - Physical Therapist Assistant (NPTE-PTA)®Physical Therapy - Sports Clinical Specialist (ABPTS® APTA® SCS)Plastic SurgeryPodiatry - APMLE® Part 1Podiatry - APMLE® Part 2Podiatry - APMLE® Part 3Podiatry Foot and Ankle SurgeryPodiatry MedicineProfessional Ethics, Leadership, and Management - Nursing StudentPsychiatryPsychiatry - AddictionPsychiatry - Child and AdolescentPsychiatry - Consultation-LiaisonPsychiatry - ForensicPsychiatry - GeriatricPsychology - Examination for Professional Practice In Psychology (EPPP®)Psychology - NeuropsychologyPsychology - Psychopharmacology Examination (PEP®)Public Health and
General Preventive MedicinePuerto Rico State CME CE RequirementsPulmonaryQuality BoardRadiation OncologyRadiologic Technologist - Magnetic Resonance Imaging (ARRT-MRI®)Radiologic Technologist - Radiography (ARRT-R®)Radiology - BreastRadiology - CardiacRadiology - Diagnostic Radiology Qualifying (Core)Radiology - GastrointestinalRadiology - GenitourinaryRadiology - MusculoskeletalRadiology - NeuroradiologyRadiology - PediatricRadiology - Physics and SafetyRadiology - ThoracicRadiology - UltrasoundRadiology - Vascular and InterventionalRadiology Technology - Computed Tomography (ARRT-CT® or NMTCB-CT®)Radiology Technology - Nuclear Medicine (ARRT® or NMTCB-CNMT®)Radiology Technology - Vascular Interventional RadiographyRegistered Cardiovascular Invasive Specialist (RCIS)®Registered Dietitian (RD®) / Registered Dietitian Nutritionist (RDN®)Respiratory Therapist - Certified or Registered (CRT® or RRT®)Respiratory Therapy - Adult Critical Care Specialist (RRT-ACCS®)Respiratory Therapy - Neonatal and Pediatric (RRT-NPS®)Respiratory Therapy - Pulmonary Function Technologist (CPFT® or RPFT®)RheumatologyRhode Island State CME CE RequirementsSleepSocial Work - ASWB® Advanced GeneralistSocial Work - ASWB® Bachelors and AssociateSocial Work - ASWB® ClinicalSocial Work - ASWB® MastersSonography - Cardiac SonographerSonography - Registered Diagnostic Medical Sonographer® (RDMS-Ob/Gyn®)Sonography - Registered Diagnostic Medical Sonographer®-Abdomen (RDMS-AB®)Sonography - Vascular (ADRMS® RVT®, ARRT® VS®, CCI® RVS®)South Carolina State CME CE RequirementsSouth Dakota State CME CE RequirementsSpeech-Language Pathology Praxis® (SLP®)SPEX®Spinal Cord Injury MedicineSpine SurgerySports MedicineSurgical Critical CareTennessee State CME CE RequirementsTexas State CME CE RequirementsThoracic SurgeryToxicologyTransesophageal EchocardiographyTransplant HepatologyUK - Medical Licensing Assessment (UKMLA/MLA)UK - Multi-Specialty Recruitment Assessment (MSRA - CPS)UK - Prescribing Safety Assessment (PSA)UK Overseas Registration (ORE)UK PLAB 1Undersea and HyperbaricUrologyUrology - PediatricUSMLE® Step 1USMLE® Step 2USMLE® Step 3Utah State CME CE RequirementsVascular Medicine (ABVMVascular Medicine (ABVM®)Vascular SurgeryVenous, Lymphatic, and Phlebology MedicineVermont State CME CE RequirementsVirgin Islands State CME CE RequirementsVirginia State CME CE RequirementsWashington State CME CE RequirementsWest Virginia State CME CE RequirementsWisconsin State CME CE RequirementsWoundWyoming State CME CE Requirements

Select Primary Specialty

  • Select Primary Specialty
  • Addiction Medicine
  • Adolescent Medicine
  • Adult Medical Surgical PN - Nursing Student
  • Adult Medical Surgical RN - Nursing Student
  • Advanced Cardiovascular Life Support® (ACLS®)
  • Advanced Diabetes Management
  • Advanced Emergency Medicine Ultrasonography® (AEMUS®)
  • Advanced Trauma Life Support® (ATLS®)
  • Aerospace Medicine
  • Alabama State CME CE Requirements
  • Alaska State CME CE Requirements
  • Allergy and Immunology
  • Anatomy and Physiology - Nursing Student
  • Anesthesiology - Adult Cardiac
  • Anesthesiology - Advanced
  • Anesthesiology - Basic
  • Anesthesiology - In-Training
  • Anesthesiology - Pediatric
  • Arizona State CME CE Requirements
  • Arkansas State CME CE Requirements
  • Audiology Praxis®
  • Australian Medical Council - IMG (AMC CAT MCQ)
  • Brain Injury Medicine (BIM®)
  • Calculations - Nursing Student
  • California State CME CE Requirements
  • Cardiac Surgery
  • Cardiology - Adult Congenital Heart Disease
  • Cardiology - Adult Echocardiography
  • Cardiology - Advanced Heart Failure and Transplant Cardiology
  • Cardiology - Cardiovascular Computed Tomography
  • Cardiology - Cardiovascular Disease
  • Cardiology - Cardiovascular Magnetic Resonance
  • Cardiology - Clinical Cardiac Electrophysiology
  • Cardiology - Interventional
  • Cardiology - Nuclear
  • Cardiothoracic - Congenital Surgery
  • Cardiothoracic Surgery
  • Caribbean Association of Medical Councils (CAMC)
  • Certified Anesthesiology Assistants (CAA®)
  • Certified Dental Assistant™ (CDA®)
  • Certified EKG Technician (CET)
  • Certified Healthcare Simulation Educator (CHSE®)
  • Certified Hyperbaric Technologist (CHT)
  • Certified Hypertension Clinician (CHC®)
  • Certified Hypertension Specialist (CHS®)
  • Certified in Healthcare Compliance (CHC®)
  • Certified Medical Assistant (AAMA® CMA®)
  • Certified Nursing Assistant (CNA®)
  • Certified Occupational Therapy Assistant® (COTA®)
  • Certified Registered Nurse Anesthetist (CRNA NCE® or SEE®)
  • Certified Surgical First Assistant™ (CSFA®)
  • Certified Surgical Technologist™ (CST®)
  • Child Health PN - Nursing Student
  • Child Health RN - Nursing Student
  • Clinical Informatics
  • Clinical Lipid Specialists (CLS®)
  • Clinical Nutritionist (CCN/CNS)
  • Clinical Tropical Medicine and Travelers' Health (CTropMed®)
  • CNS - Acute Care Clinical Nurse Specialist - Neonatal (ACCNS-N®)
  • CNS - Acute Care Clinical Nurse Specialist - Pediatric (ACCNS-P®)
  • CNS - Adult-Gerontology Clinical Nurse Specialist (ACCNS-AG® or AGCNS-BC™)
  • CNS - Advanced Diabetes Management (BC-ADM®)
  • Colon and Rectal Surgery / Colorectal
  • Colorado State CME CE Requirements
  • COMLEX-USA® Level 1
  • COMLEX-USA® Level 2
  • COMLEX-USA® Level 3
  • Community Health - Nursing Student
  • Complex General Surgical Oncology (CGSO®)
  • COMVEX®
  • Connecticut State CME CE Requirements
  • Correctional Medicine
  • Cosmetic Surgery (ABCS®)
  • Critical Care and Basic Rhythms - Nursing Student
  • Critical Care Medicine
  • Delaware State CME CE Requirements
  • Dental Licensure Objective Structured Clinical Examination (DLOSCE™)
  • Dermatology - Applied
  • Dermatology - Basic
  • Dermatology - Core
  • Dermatology - Micrographic Dermatologic Surgery (Mohs)
  • Dermatology - Pediatric
  • Dermatopathology
  • Disaster Medicine
  • District of Columbia CME CE Requirements
  • Egyptian Medical Licensing Exam (EMLE)
  • Elder Adult Care - Nursing Student
  • Emergency Medicine
  • Emergency Medicine - Emergency Medical Services (ABEM® EMS®)
  • Emergency Medicine - FRCEM SBA
  • Emergency Medicine - MRCEM Primary
  • Emergency Medicine - MRCEM SBA-FRCEM Intermediate
  • Emirates Medical Residency Entrance Examination (EMREE)
  • EMS - Advanced Emergency Medical Technician (NREMT® AEMT®)
  • EMS - Certified Flight Paramedic (IBSC FP-C®)
  • EMS - Community Paramedic (IBSC CP-C®)
  • EMS - Critical Care Paramedic (IBSC CCP-C®)
  • EMS - Emergency Medical Responder (NREMT® EMR®)
  • EMS - Emergency Medical Technician (NREMT® EMT®)
  • EMS - Paramedic (NREMT®)
  • EMS - Tactical Paramedic Certification (IBSC TP-C®)
  • EMS - Wilderness Paramedic (IBSC WP-C®)
  • ENARM Mexico
  • Endocrinology
  • Endovascular Medicine
  • Facial Cosmetic Surgery
  • Facial Plastic and Reconstructive Surgery
  • Family Medicine
  • Family Medicine - MRCGP-Applied Knowledge Test
  • Florida State CME CE Requirements
  • Fundamentals - Nursing Student
  • Gastroenterology
  • General Surgery
  • General Surgery - In-Training ABSITE®
  • General Surgery Review (All Subspecialties) - MRCS Part A
  • Genetics and Genomics - Clinical
  • Genetics and Genomics - General
  • Georgia State CME CE Requirements
  • Geriatrics
  • Guam State CME CE Requirements
  • Hand Surgery
  • Hawaii State CME CE Requirements
  • Health Assessment - Nursing Student
  • Healthcare Administration, Leadership, and Management (HALM®)
  • Healthcare Ethics Consultant Exam (HEC-C)
  • Hematology
  • Hospice And Palliative Medicine
  • Idaho State CME CE Requirements
  • Illinois State CME CE Requirements
  • Indian PG Entrance (NEET-PG)
  • Indiana State CME CE Requirements
  • Infectious Disease
  • Integrated National Board Dental Examination (INBDE®)
  • Internal Medicine
  • Internal Medicine - Focused Practice In Hospital Medicine
  • Internal Medicine - MRCP UK and Ireland Part 1
  • Internal Medicine - MRCP UK and Ireland Part 2
  • International Trauma Life Support® (ITLS®)
  • Iowa State CME CE Requirements
  • Kansas State CME CE Requirements
  • Kentucky State CME CE Requirements
  • Lab - Medical Laboratory Scientist MLS(ASCP®)
  • Lab - Medical Laboratory Technician MLT(ASCP®)
  • Lab - Phlebotomy Technician PBT(ASCP®) or (NPS CPT®)
  • Lab - Technologist in Blood Banking BB(ASCP®)
  • Lab - Technologist in Chemistry C(ASCP®)
  • Lab - Technologist in Hematology H(ASCP®)
  • Lab - Technologist in Microbiology M(ASCP®)
  • Lab and Diagnostic Testing - Nursing Student
  • Lifestyle Medicine
  • Louisiana State CME CE Requirements
  • Maine State CME CE Requirements
  • Maryland State CME CE Requirements
  • Massachusetts State CME CE Requirements
  • Maternal Newborn PN - Nursing Student
  • Maternal Newborn RN - Nursing Student
  • MCCQE Part I (Medical Council of Canada Qualifying Examination)
  • Medical Council Nigeria (MDCN)
  • Medical Student Elective - Allergy
  • Medical Student Elective - Anesthesiology
  • Medical Student Elective - Biostatistics and Economics
  • Medical Student Elective - Cardiothoracic Surgery
  • Medical Student Elective - Cardiovascular Disease
  • Medical Student Elective - Critical Care
  • Medical Student Elective - Dermatology
  • Medical Student Elective - Diagnostic Radiology
  • Medical Student Elective - ECG and Rhythm Strip Review
  • Medical Student Elective - Endocrinology
  • Medical Student Elective - Gastroenterology
  • Medical Student Elective - Genetics
  • Medical Student Elective - Geriatrics
  • Medical Student Elective - Hand
  • Medical Student Elective - Hematology
  • Medical Student Elective - Infectious Disease
  • Medical Student Elective - Law, Medicine, and Ethics
  • Medical Student Elective - Neonatology
  • Medical Student Elective - Nephrology
  • Medical Student Elective - Neurosurgery
  • Medical Student Elective - Oncology
  • Medical Student Elective - Ophthalmology
  • Medical Student Elective - Orthopedic
  • Medical Student Elective - Otolaryngology
  • Medical Student Elective - Pathology, Clinical Laboratory
  • Medical Student Elective - Pediatric Cardiology
  • Medical Student Elective - Pediatric Critical Care
  • Medical Student Elective - Pediatric Endocrinology
  • Medical Student Elective - Pediatric Gastroenterology
  • Medical Student Elective - Pediatric Hematology & Oncology
  • Medical Student Elective - Pediatric Infectious Diseases
  • Medical Student Elective - Pediatric Nephrology
  • Medical Student Elective - Pediatric Neurology
  • Medical Student Elective - Pediatric Pulmonology
  • Medical Student Elective - Pediatric Surgery
  • Medical Student Elective - Physical Medicine and Rehabilitation
  • Medical Student Elective - Plastic Surgery
  • Medical Student Elective - Pulmonology
  • Medical Student Elective - Rheumatology
  • Medical Student Elective - Sports Medicine
  • Medical Student Elective - Urology
  • Medical Student Elective - Vascular Surgery
  • Mental Health PN - Nursing Student
  • Mental Health RN - Nursing Student
  • Metabolic and Bariatric Surgery (MBS FPD®)
  • Michigan State CME CE Requirements
  • Microbiology - Nursing Student
  • Minnesota State CME CE Requirements
  • Mississippi State CME CE Requirements
  • Missouri State CME CE Requirements
  • Montana State CME CE Requirements
  • Multistate Pharmacy Jurisprudence Examination® (MPJE®)
  • National Board Dental Hygienist Examination (NBDHE®)
  • NBME® Shelf - Ambulatory Care
  • NBME® Shelf - Anatomy
  • NBME® Shelf - Behavioral Science
  • NBME® Shelf - Biochemistry
  • NBME® Shelf - Clinical Neurology
  • NBME® Shelf - Comprehensive Basic Science (CBSE®)
  • NBME® Shelf - Comprehensive Clinical Science (CCC®)
  • NBME® Shelf - Embryology
  • NBME® Shelf - Emergency Medicine
  • NBME® Shelf - Family Medicine
  • NBME® Shelf - Health Systems Science
  • NBME® Shelf - Histology
  • NBME® Shelf - Internal Medicine (Advanced Clinical Exam)
  • NBME® Shelf - Introduction to Clinical Diagnosis
  • NBME® Shelf - Medicine
  • NBME® Shelf - Microbiology and Immunology
  • NBME® Shelf - Neuroscience
  • NBME® Shelf - Obstetrics and Gynecology
  • NBME® Shelf - Pathology
  • NBME® Shelf - Pediatrics
  • NBME® Shelf - Pharmacology
  • NBME® Shelf - Physiology
  • NBME® Shelf - Psychiatry
  • NBME® Shelf - Surgery
  • NBOME® Subject Exam / Shelf - Osteopathic Principles and Practice
  • NCLEX-PN® - Nursing Student
  • NCLEX-RN® - Nursing Student
  • Nebraska State CME CE Requirements
  • Nepal Medical Council Licensing Examination (NMCLE)
  • Nephrology
  • Neurology
  • Neurology - Behavioral Neurology and Neuropsychiatry
  • Neurology - Clinical Neurophysiology
  • Neurology - Epilepsy Medicine
  • Neurology - Headache
  • Neurology - Neurocritical Care
  • Neurology - Neurodevelopmental Disabilities
  • Neurology - Neuromuscular Medicine
  • Neurology - Vascular Neurology
  • Neurosurgery
  • Nevada State CME CE Requirements
  • New Hampshire State CME CE Requirements
  • New Jersey State CME CE Requirements
  • New Mexico State CME CE Requirements
  • New York State CME CE Requirements
  • North Carolina State CME CE Requirements
  • North Dakota State CME CE Requirements
  • NP - Adult-Gerontology Acute Care Nurse Practitioner (AGACNP® or ACNPC-AG®)
  • NP - Adult-Gerontology Primary Care Nurse Practitioner (AGPCNP® or AGNP®)
  • NP - Advanced Certified Hospice and Palliative Nurse (ACHPN®)
  • NP - Advanced Health Assessment and Diagnostic Reasoning Nurse Practitioner
  • NP - Advanced Neurovascular Practitioner Certification (ANVP-BC®)
  • NP - Advanced Oncology Certified Nurse Practitioner (AOCNP®)
  • NP - Advanced Pathophysiology Nurse Practitioner
  • NP - Advanced Pharmacology Nurse Practitioner
  • NP - Advanced Physiology Nurse Practitioner
  • NP - Biostatistics and Epidemiology Nurse Practitioner
  • NP - Board Certified Advanced Diabetes Management (BC-ADM®)
  • NP - Cardiovascular Nurse Practitioner (CVNP-BC®)
  • NP - Certified Addictions Registered Nurse - Advanced Practice (CARN-AP®)
  • NP - Certified Continence Care Nurse - Advanced Practice (CCCN-AP®)
  • NP - Certified Midwife (CNM®/CM®)
  • NP - Certified Nephrology Nurse - Nurse Practitioner™ (CNN-NP™)
  • NP - Certified Ostomy Care Nurse - Advanced Practice (COCN-AP®)
  • NP - Certified Pediatric Nurse Practitioner - Acute Care (CPNP-AC®)
  • NP - Certified Pediatric Nurse Practitioner – Primary Care (CPNP-PC®)
  • NP - Certified Urologic Nurse Practitioner (CUNP®)
  • NP - Certified Wound Care Nurse - Advanced Practice (CWCN-AP® / AWCC™)
  • NP - Certified Wound Ostomy Continence Nurse - Adv. Practice (CWOCN-AP®)
  • NP - Dermatology Certified Nurse Practitioner (DCNP®)
  • NP - Emergency Nurse Practitioner (ENP®)
  • NP - Ethics & Legal Issues Nurse Practitioner
  • NP - Family Nurse Practitioner (ANCC/FNP-BC™ or AANP/FNP-C®)
  • NP - Health Promotion and Disease Prevention Nurse Practitioner
  • NP - Neonatal Nurse Practitioner (NNP-BC®)
  • NP - Nurse Executive Advanced Certification (NEA-BC®)
  • NP - Orthopedic Nurse Practitioner (ONP-C®)
  • NP - Pediatric Primary Care Mental Health Specialist (PMHS®)
  • NP - Psychiatric-Mental Health Nurse Practitioner Certification (PMHNP-BC™)
  • NP - Theory and Evidence-Based Practice Nurse Practitioner
  • NP - Women's Health Nurse Practitioner (WHNP®)
  • Nuclear Medicine
  • Nurse - Ambulatory Care Nursing Certification (AMB-BC™)
  • Nurse - Assisted Living Nursing Certification (C-AL®)
  • Nurse - Bariatric (CBN®)
  • Nurse - Cardiac Medicine Certification (CMC®) Adult
  • Nurse - Cardiac-Vascular Nursing Certification (CV-BC™)
  • Nurse - Cardiovascular Nursing (CVN®)
  • Nurse - Case Management Certification (CMGT-BC™)
  • Nurse - Certified Addictions Registered Nurse (CARN®)
  • Nurse - Certified Anticoagulation Care Provider (CACP®)
  • Nurse - Certified Breast Care Nurse (CBCN®)
  • Nurse - Certified Clinical Transplant Nurse (CCTN®)
  • Nurse - Certified Continence Care Nurse (CCCN®)
  • Nurse - Certified Diabetes Care and Education Specialist® (CDCES®)
  • Nurse - Certified Emergency Nurse® (CEN®)
  • Nurse - Certified Flight Registered Nurse (CFRN®)
  • Nurse - Certified Foot Care Nurse (CFCN®)
  • Nurse - Certified Gastroenterology Registered Nurse (CGRN®)
  • Nurse - Certified Hemodialysis Nurse (CHN®)
  • Nurse - Certified Hospice and Palliative Nurse (CHPN®)
  • Nurse - Certified Hyperbaric Registered Nurse® (CHRN®)
  • Nurse - Certified Infection Control (CIC®)
  • Nurse - Certified Managed Care Nurse (CMCN®)
  • Nurse - Certified Nephrology Nurse (CNN®)
  • Nurse - Certified Neuroscience Registered Nurse (CNRN®)
  • Nurse - Certified Nurse Educator (CNE®)
  • Nurse - Certified Nurse Manager and Leader (CNML®)
  • Nurse - Certified Occupational Health Nurse (COHN® and COHN-S®)
  • Nurse - Certified Ostomy Care (COCN®) / Ostomy Management Specialist (OMS®)
  • Nurse - Certified Otorhinolaryngology Nurse (CORLN®)
  • Nurse - Certified Pediatric Emergency Nurse (CPEN®)
  • Nurse - Certified Pediatric Hematology Oncology Nurse (CPHON®)
  • Nurse - Certified Pediatric Nurse (CPN®)
  • Nurse - Certified Perioperative Nurse (CNOR®)
  • Nurse - Certified Peritoneal Dialysis Nurse (CPDN®)
  • Nurse - Certified Plastic Surgery Nurse (CPSN®)
  • Nurse - Certified Post and Ambulatory Perianesthesia Nurse (CPAN® / CAPA®)
  • Nurse - Certified Professional in Health Care Risk Management (CPHRM®)
  • Nurse - Certified Professional in Healthcare Quality (CPHQ®)
  • Nurse - Certified Radiology Nurse (CRN©)
  • Nurse - Certified Registered Nurse in Ophthalmology (CRNO®)
  • Nurse - Certified Registered Nurse Infusion (CRNI®)
  • Nurse - Certified Rehabilitation Registered Nurse (CRRN®)
  • Nurse - Certified Transport Registered Nurse (CTRN®)
  • Nurse - Certified Urologic Registered Nurse (CURN®)
  • Nurse - Certified Wound Care Nurse (CWCN® / WCC®)
  • Nurse - Critical Care Registered Nurse - Adult (CCRN®)
  • Nurse - Critical Care Registered Nurse - Neonatal (CCRN®)
  • Nurse - Critical Care Registered Nurse - Pediatric (CCRN®)
  • Nurse - Dermatology Nurse Certified (DNC®)
  • Nurse - Emergency Nurse Pediatric Certification© (ENPC®)
  • Nurse - Gerontology Nursing Certification (GERO-BC™)
  • Nurse - Informatics Nursing Certification (NI-BC™)
  • Nurse - Inpatient Obstetric Nursing (RNC-OB®)
  • Nurse - International Board Certified Lactation Consultant® (IBCLC®)
  • Nurse - Low Risk Neonatal Intensive Care Nursing (RNC-LRN®)
  • Nurse - Maternal Newborn Nursing (MNN®)
  • Nurse - Medical-Surgical Nursing Certification (MEDSURG-BC™)
  • Nurse - Nationally Certified School Nurse (NCSN®)
  • Nurse - Neonatal Pediatric Transport (C-NPT®)
  • Nurse - Nurse Executive Certification (NE-BC®)
  • Nurse - Nursing Professional Development Certification (NPD-BC™)
  • Nurse - Oncology Certified Nurse (OCN®)
  • Nurse - Orthopedic Nurse Certification (ONC®)
  • Nurse - Pain Management Nursing Certification (PMGT-BC™)
  • Nurse - Progressive Care Certified Nurse (PCCN®) - Adult
  • Nurse - Psychiatric-Mental Health Nursing Certification (PMH-BC™)
  • Nurse - Registered Nurse First Assistant (RNFA©)
  • Nurse - Sexual Assault Nurse Examiner (SANE®)
  • Nurse - Stroke Certified Registered Nurse (SC-RN®)
  • Nurse - Trauma Certified Registered Nurse (TCRN®)
  • Nurse - Vascular Access Board Certified Nursing (VA-BC®)
  • Nutrition - Nursing Student
  • Nutrition Medicine
  • Obesity Medicine
  • Ob-Gyn - CREOG® In-Service
  • Ob-Gyn - Gynecologic Oncology
  • Ob-Gyn - Maternal-Fetal Medicine
  • Ob-Gyn - MRCOG UK and Ireland Part 1
  • Ob-Gyn - MRCOG UK and Ireland Part 2 and Part 3
  • Ob-Gyn - Obstetrics and Gynecology
  • Ob-Gyn - Reproductive Endocrinology and Infertility
  • Ob-Gyn - Urogynecology and Reconstructive Pelvic Surgery
  • Occupational Medicine
  • Occupational Therapist Registered (NBCOT® OTR®)
  • Ohio State CME CE Requirements
  • Oklahoma State CME CE Requirements
  • Oncology
  • Ophthalmology
  • Ophthalmology - Cataract
  • Ophthalmology - Cornea and External Eye Disease
  • Ophthalmology - Glaucoma
  • Ophthalmology - Medical and Surgical Retina
  • Ophthalmology - Neuro-Ophthalmology
  • Ophthalmology - Oculoplastic Surgery
  • Ophthalmology - Optics
  • Ophthalmology - Pediatric and Strabismus
  • Ophthalmology - Uveitis
  • Ophthamology - Trauma
  • Optometry - Advanced Medical Care
  • Optometry - Applied Basic Science (ABS®)
  • Optometry - Patient Assessment and Management (PAM®)
  • Oral And Maxillofacial Surgery
  • Oregon State CME CE Requirements
  • Orthopedic Surgery
  • Osteopathic Neuromusculoskeletal Medicine (OMT/NMM®/OMM®)
  • Otolaryngology - Head and Neck Surgery
  • PA - Cardiovascular and Thoracic Surgery (CAQ-CVTS®)
  • PA - Cardiovascular Physician Assistant/Associate (CVPA-BC®)
  • PA - Clinical Knowledge Rating and Assessment
  • PA - Dermatology (CAQ-Derm® or NBDPA™)
  • PA - Emergency Medicine (CAQ-EM®)
  • PA - Emergency Medicine End of Rotation
  • PA - End of Curriculum
  • PA - Family Medicine End of Rotation
  • PA - Hospital Medicine (CAQ-HM®)
  • PA - Internal Medicine End of Rotation
  • PA - Nephrology (CAQ-Neph®)
  • PA - Obstetrics and Gynecology (CAQ-OBGYN®)
  • PA - Occupational Medicine (CAQ-OM®)
  • PA - Orthopedic (CAQ-OS®)
  • PA - Palliative Medicine and Hospice Care (CAQ-PMHC®)
  • PA - PANCE®
  • PA - PANRE®
  • PA - Pediatric (CAQ-Peds®)
  • PA - Pediatric End of Rotation
  • PA - Psychiatric and Behavioral Health End of Rotation
  • PA - Psychiatry (CAQ-Psy®)
  • PA - Surgery End of Rotation
  • PA - Womens Health End of Rotation (Gyn, Sexual, & Reproductive Health)
  • Pain Medicine
  • Pakistan - 1st Professional MBBS
  • Pakistan - 2nd Professional MBBS
  • Pakistan - 3rd Professional MBBS
  • Pakistan - 4th Professional MBBS
  • Pakistan - Final Professional MBBS
  • Pakistan FCPS Part I (Basic Science)
  • Pathology - Anatomic
  • Pathology - Blood Banking Transfusion Medicine
  • Pathology - Chemical
  • Pathology - Clinical
  • Pathology - Cytopathology
  • Pathology - Forensics
  • Pathology - Hematopathology
  • Pathology - Microbiology
  • Pathology - Molecular Genetic
  • Pathology - Neuropathology
  • Pathology - Pediatric
  • Pathophysiology - Nursing Student
  • Pediatric
  • Pediatric - Cardiology
  • Pediatric - Child Abuse
  • Pediatric - Critical Care
  • Pediatric - Developmental Behavioral
  • Pediatric - Emergency Medicine
  • Pediatric - Endocrinology
  • Pediatric - Gastroenterology
  • Pediatric - Hematology-Oncology
  • Pediatric - Hospital Medicine
  • Pediatric - Infectious Diseases
  • Pediatric - MRCPCH UK
  • Pediatric - Neonatal Perinatal
  • Pediatric - Nephrology
  • Pediatric - Neurology
  • Pediatric - Pulmonology
  • Pediatric - Rehabilitation Medicine
  • Pediatric - Rheumatology
  • Pediatric Advanced Life Support® (PALS®)
  • Pediatric Surgery
  • Pennsylvania State CME CE Requirements
  • Pharmacology PN - Nursing Student
  • Pharmacology RN - Nursing Student
  • Pharmacy - Ambulatory Care (BCACP®)
  • Pharmacy - Applied Toxicology (ABAT®)
  • Pharmacy - Cardiology (BCCP®)
  • Pharmacy - Certified Pharmacy Technician (PTCB® CPhT®)
  • Pharmacy - Critical Care (BCCCP®)
  • Pharmacy - Emergency Medicine (BCEMP®)
  • Pharmacy - Geriatric (BCGP®)
  • Pharmacy - Infectious Disease (BCIDP®)
  • Pharmacy - NAPLEX®
  • Pharmacy - Nutrition Support (BCNSP®)
  • Pharmacy - Oncology (BCOP®)
  • Pharmacy - Pediatric (BCPPS®)
  • Pharmacy - Pharmacotherapy (BCPS®)
  • Pharmacy - Psychiatric (BCPP®)
  • Physical Medicine and Rehabilitation
  • Physical Therapy - Geriatric Clinical Specialist (ABPTS® APTA® GCS)
  • Physical Therapy - Neurology Clinical Specialist (ABPTS® APTA® NCS)
  • Physical Therapy - Orthopedic Clinical Specialist (ABPTS® APTA® OCS)
  • Physical Therapy - Pediatric Clinical Specialist (ABPTS® APTA® PCS)
  • Physical Therapy - Physical Therapist (NPTE-PT)®
  • Physical Therapy - Physical Therapist Assistant (NPTE-PTA)®
  • Physical Therapy - Sports Clinical Specialist (ABPTS® APTA® SCS)
  • Plastic Surgery
  • Podiatry - APMLE® Part 1
  • Podiatry - APMLE® Part 2
  • Podiatry - APMLE® Part 3
  • Podiatry Foot and Ankle Surgery
  • Podiatry Medicine
  • Professional Ethics, Leadership, and Management - Nursing Student
  • Psychiatry
  • Psychiatry - Addiction
  • Psychiatry - Child and Adolescent
  • Psychiatry - Consultation-Liaison
  • Psychiatry - Forensic
  • Psychiatry - Geriatric
  • Psychology - Examination for Professional Practice In Psychology (EPPP®)
  • Psychology - Neuropsychology
  • Psychology - Psychopharmacology Examination (PEP®)
  • Public Health and
General Preventive Medicine
  • Puerto Rico State CME CE Requirements
  • Pulmonary
  • Quality Board
  • Radiation Oncology
  • Radiologic Technologist - Magnetic Resonance Imaging (ARRT-MRI®)
  • Radiologic Technologist - Radiography (ARRT-R®)
  • Radiology - Breast
  • Radiology - Cardiac
  • Radiology - Diagnostic Radiology Qualifying (Core)
  • Radiology - Gastrointestinal
  • Radiology - Genitourinary
  • Radiology - Musculoskeletal
  • Radiology - Neuroradiology
  • Radiology - Pediatric
  • Radiology - Physics and Safety
  • Radiology - Thoracic
  • Radiology - Ultrasound
  • Radiology - Vascular and Interventional
  • Radiology Technology - Computed Tomography (ARRT-CT® or NMTCB-CT®)
  • Radiology Technology - Nuclear Medicine (ARRT® or NMTCB-CNMT®)
  • Radiology Technology - Vascular Interventional Radiography
  • Registered Cardiovascular Invasive Specialist (RCIS)®
  • Registered Dietitian (RD®) / Registered Dietitian Nutritionist (RDN®)
  • Respiratory Therapist - Certified or Registered (CRT® or RRT®)
  • Respiratory Therapy - Adult Critical Care Specialist (RRT-ACCS®)
  • Respiratory Therapy - Neonatal and Pediatric (RRT-NPS®)
  • Respiratory Therapy - Pulmonary Function Technologist (CPFT® or RPFT®)
  • Rheumatology
  • Rhode Island State CME CE Requirements
  • Sleep
  • Social Work - ASWB® Advanced Generalist
  • Social Work - ASWB® Bachelors and Associate
  • Social Work - ASWB® Clinical
  • Social Work - ASWB® Masters
  • Sonography - Cardiac Sonographer
  • Sonography - Registered Diagnostic Medical Sonographer® (RDMS-Ob/Gyn®)
  • Sonography - Registered Diagnostic Medical Sonographer®-Abdomen (RDMS-AB®)
  • Sonography - Vascular (ADRMS® RVT®, ARRT® VS®, CCI® RVS®)
  • South Carolina State CME CE Requirements
  • South Dakota State CME CE Requirements
  • Speech-Language Pathology Praxis® (SLP®)
  • SPEX®
  • Spinal Cord Injury Medicine
  • Spine Surgery
  • Sports Medicine
  • Surgical Critical Care
  • Tennessee State CME CE Requirements
  • Texas State CME CE Requirements
  • Thoracic Surgery
  • Toxicology
  • Transesophageal Echocardiography
  • Transplant Hepatology
  • UK - Medical Licensing Assessment (UKMLA/MLA)
  • UK - Multi-Specialty Recruitment Assessment (MSRA - CPS)
  • UK - Prescribing Safety Assessment (PSA)
  • UK Overseas Registration (ORE)
  • UK PLAB 1
  • Undersea and Hyperbaric
  • Urology
  • Urology - Pediatric
  • USMLE® Step 1
  • USMLE® Step 2
  • USMLE® Step 3
  • Utah State CME CE Requirements
  • Vascular Medicine (ABVMVascular Medicine (ABVM®)
  • Vascular Surgery
  • Venous, Lymphatic, and Phlebology Medicine
  • Vermont State CME CE Requirements
  • Virgin Islands State CME CE Requirements
  • Virginia State CME CE Requirements
  • Washington State CME CE Requirements
  • West Virginia State CME CE Requirements
  • Wisconsin State CME CE Requirements
  • Wound
  • Wyoming State CME CE Requirements

reCAPTCHA

Recaptcha requires verification.

I'm not a robot

reCAPTCHA

Create Account

Learn more about a Subscription to StatPearls Point-of-Care

Already have an account? Log in

Etiology

As noted, thrombosis occurs when there is an imbalance in endogenous anticoagulation and hemostasis. Historically, three common factors predispose to thrombosis: 1) damage to the endothelial lining of a vessel wall 2) hypercoagulable state 3) arterial or venous blood stasis. These three factors are known by the eponym "Virchow's triad," described by Rudolf Virchow in 1856. Endothelial wall damage is caused by different factors. Direct causes include disruption of the vessel via catheter placement, trauma, or surgery. Indirect causes include inflammatory factors, disruption of intracellular junctions, and tissue factor expression. [[2]](/content/point-of-care/30111#ref_18645567 ""/index.html)

Hypercoagulability is a general hematologic concept that means an increased risk of thrombosis via enhanced levels of prothrombotic components in the bloodstream. This hypercoagulability is due to a variety of alterations in the hemostatic system, which can result from inflammatory factors, increased viscosity of blood and blood components, cytokine release, prothrombotic proteins in circulation, and deficiencies of endogenous anticoagulant factors.

Hypercoagulable states can be acquired or inherited. The most common inherited forms include loss of function mutations (antithrombin III deficiency, protein C and S deficiencies) and gain of function mutations (factor V Leiden and prothrombin gene mutations.) Acquired hypercoagulability is far more common and can result from medications (eg, oral contraceptives, estrogen, or other hormonal replacement); acute inflammatory conditions such as pregnancy, surgery, trauma, or infection; and chronic inflammatory conditions, such as morbid obesity, rheumatologic disease, ulcerative colitis, heavy smoking. Two specific types of acquired hypercoagulable states that can lead to both venous and arterial thrombus include acquired antiphospholipid syndrome (APS) and heparin-induced thrombocytopenia & thrombosis (HITT). Malignancy is also a well-known risk factor for hypercoagulability, as tumor cells can express a variety of procoagulant proteins, including increased expression tissue factor.  Some malignancies, such as pancreatic cancer, are known to increase the risk of thrombosis significantly. Another risk factor for thrombosis is increased cellular blood components such in polycythemia vera or essential thrombocytosis. Please see our companion article, "Myeloproliferative Neoplasms" for further information. [[3]](/content/point-of-care/30111#ref_30285359 ""/index.html) [[4]](/content/point-of-care/30111#ref_31395856 ""/index.html)

The third aspect of Virchow's triad includes arterial or venous stasis of the blood, which can be due to immobility, pregnancy, or impaired blood flow resulting from previous thrombosis (eg, residual blood clot, remodeling or fibrosis of blood vessels, or atherosclerosis). Long plane or car trips with limited mobility can also become a relative risk factor for thrombosis, especially if additional predisposing factors are present.

Typically, venous thrombosis is initiated by endothelial damage, while arterial thrombosis starts with atherosclerosis. However, some studies have proven that there is a link between these two types of thrombosis through activated coagulation and inflammatory pathways. [[5]](/content/point-of-care/30111#ref_27628000 ""/index.html) Both kinds of thrombosis have similar risk factors, including age, obesity, smoking, chronic inflammation, and metabolic syndrome. It is paramount to determine whether the thrombosis was likely provoked or unprovoked, as each has management implications. Knowledge of the location (proximal or distal) and extent of the thrombosis can also guide further workup and may alter the treatment approach.

Vemous thromboemolisms (VTEs) usually manifest as deep venous thromboses (DVTs) or pulmonary embolisms (PE). When considering VTE, an appreciation of the anatomy of the deep veins of the extremities and the pulmonary system is helpful. For example, the deep veins of the lower extremity include the femoral, iliac, and popliteal veins. Thrombosis can also occur in the veins of the upper extremity, such as the subclavian, axillary, and brachial veins. Other thrombosis sites include the superior vena cava, jugular vein, cerebral venous sinus, cavernous sinus, and retinal vein. The latter sites are less common, and with the identification of an isolated thrombus in one of these sites, one must consider the potential for other explanatory diagnoses or predisposing conditions (eg, hepatic thrombus due to cirrhosis). Thrombosis of superficial veins is also possible, especially with provoking factors such as intravenous catheterization or localized cellulitis; treatment of superficial vein thrombosis does not typically require any anticoagulation. [[6]](/content/point-of-care/30111#ref_32654082 ""/index.html)

As noted, arterial thrombosis can present as an acute stroke, myocardial infarction, or both acute and chronic peripheral arterial disease. Other less common sites include renal arteries, mesenteric arteries, and retinal arteries.  In addition to acute management, secondary prevention focuses on reducing cardiovascular risk factors such as obesity, high cholesterol, diabetes, and high blood pressure and encouraging lifestyle modification such as smoking cessation. [[7]](/content/point-of-care/30111#ref_15063477 ""/index.html) Other risk factors include underlying connective tissue or rheumatologic conditions, such as systemic lupus erythematous or vasculitis. as well as the aforementioned rare HITT, antiphospholipid syndrome, myeloproliferative disorders, and paroxysmal nocturnal hemoglobinuria (all of these can predispose to both venous and arterial thrombosis.)

Age also contributes to the development of thrombosis. For instance, studies have shown that older patients have increased production of prothrombotic coagulation factors such as von Willebrand factor and thrombin, as well as more physiologic activation of platelets compared to younger patients. [[8]](/content/point-of-care/30111#ref_25099191 ""/index.html)

Epidemiology

The epidemiology of thrombosis varies depending on whether venous or arterial, provoked or unprovoked, and the first or subsequent episode. For venous thromboembolism (VTE), the annual incidence is 1 per 100000 in children, 1 per 10000 in reproductive age, 1 per 1000 in later middle age, and 1 per 100 in older patients. [[9]](/content/point-of-care/30111#ref_17367492 ""/index.html) Reports also indicate that the incidence of PE is 29 to 48 per 100,000 person-years, and DVT incidence is 45 to 117 per 100,000 person-years. [[10]](/content/point-of-care/30111#ref_26780736 ""/index.html) Studies demonstrate that there is an increased incidence of venous thrombosis in people of European descent compared with non-Europeans. [[11]](/content/point-of-care/30111#ref_24283769 ""/index.html) [[12]](/content/point-of-care/30111#ref_20345707 ""/index.html)

Patients with cancer have a 4-fold to 7-fold risk of VTE compared to those without cancer, and these usually occur in the first few months after diagnosis. [[13]](/content/point-of-care/30111#ref_32645431 ""/index.html) A scoring system was designed to predict recurrent VTE risk in the first 6 months of anticoagulation therapy in patients with malignancy called the Ottawa score. Stratification criteria include sex, cancer type and stage, and prior VTE. [[14]](/content/point-of-care/30111#ref_36485139 ""/index.html)

Pregnancy is a period of particularly high risk for thrombosis, causing a relative risk increase of 5 to 10 times baseline due to a combination of increased coagulation factors, increased venous compliance resulting in stasis, and complications such as hypertension. [[15]](/content/point-of-care/30111#ref_32768092 ""/index.html) The presence of a thrombophilic defect further amplifies this risk several-fold, and venous strokes are especially prevalent in this population. [[16]](/content/point-of-care/30111#ref_26780744 ""/index.html) [[15]](/content/point-of-care/30111#ref_32768092 ""/index.html) Another condition affecting primarily women is APS with an estimated incidence at 50 per 100,000 people, with a female-to-male ratio of approximately 5:1. [[17]](/content/point-of-care/30111#ref_33100166 ""/index.html)

Pathophysiology

As noted, Virchow's triad (ie, endothelial damage, hypercoagulability, and venous or arterial blood stasis) plays a significant role in the pathophysiology of thrombosis. Damage to the vessel wall leads to the production of pro-inflammatory cytokines, increased expression of tissue factor, proliferation of adhesion molecules, and enhanced platelet activation. [[18]](/content/point-of-care/30111#ref_29872658 ""/index.html) Inflammation is a normal body reaction to unwanted stimuli such as foreign pathogens or infection and endothelial damage, whether acute (eg, trauma or surgery) or chronic (underlying inflammatory disorders or peripheral vascular disease). The activation of the leucocytes and endothelial cells causes the formation of adhesion molecules, which will eventually initiate clot formation. [[18]](/content/point-of-care/30111#ref_29872658 ""/index.html) The body's endogenous anticoagulants, such as proteins C and S and antithrombin III, prevent the formation of thrombosis. When an imbalance exists in the formation and lysis of clots, thrombosis occurs; this explains why patients with thrombophilias such as protein C, protein S, and antithrombin III deficiencies are prone to acquiring blood clots.

In recent times, COVID-19 has appeared as a deadly disease due to a hypercoagulable state, with the widespread presence of venous and arterial thrombi. [[19]](/content/point-of-care/30111#ref_32857878 ""/index.html) [[20]](/content/point-of-care/30111#ref_37546104 ""/index.html) One belief is that the development of a cytokine storm and endothelial dysfunction leads to significant VTE. Elevated levels of D-dimer and fibrin degradation products (FDP) are associated with significant morbidity and mortality. [[21]](/content/point-of-care/30111#ref_32311448 ""/index.html) COVID patients were also found to have high rates of lupus anticoagulant development. The macrophage activation syndrome, the complement cascade, and the renin-angiotensin system are also implicated. The American Society of Chest Physicians recommends that patients who experience VTE in the setting of COVID-19 should be anticoagulated for 3 to 6 months. [[22]](/content/point-of-care/30111#ref_35398318 ""/index.html) The risk of arterial thromboembolism in the form of acute coronary syndrome and stroke is also increased in patients hospitalized with COVID-19. Recommendations are to continue antiplatelet therapy in patients already prescribed this for CAD, PAD, or a history of stroke. Dual antiplatelet therapy is recommended if a patient already on an antiplatelet agent has acute coronary syndrome but not if the patient has elevated cardiac enzymes without acute coronary syndrome. It is also recommended that hospitalized patients who develop atrial fibrillation should be started on anticoagulation, to be continued indefinitely depending on risk factors. [[23]](/content/point-of-care/30111#ref_37392958 ""/index.html) The vaccines used to combat COVID can themselves have the propensity for VTE. This very rare condition has been found in both mRNA and adenovector vaccines (available outside the US) and is thought to be mediated by a reaction similar to HITT. [[24]](/content/point-of-care/30111#ref_34912330 ""/index.html) [[25]](/content/point-of-care/30111#ref_33987882 ""/index.html)

Thrombosis occurs throughout the arterial system and is responsible for mortality from CVAs and MIs. In the heart, microthrombi can develop as a result of blood stasis in the ventricles or atria due to underlying valvular heart disease, cardiomyopathies, or arrhythmias such as atrial fibrillation predisposing to ischemic emboli and CVA. Arterial thrombosis is typically initiated by the accumulation of lipid plaques in the arterial wall, provoking chronic inflammatory cells and platelet activation. [[26]](/content/point-of-care/30111#ref_19110086 ""/index.html) Platelets play a significant role in the development of arterial thrombosis compared to venous thrombosis, and this explains why antiplatelet agents form a cornerstone of the prevention and treatment of arterial thrombosis. The initial lipid plaques evolve into fibrous plaques. Fibrous plaques can rupture, and the erosion of the surfaces of some of these plaques can lead to the release of additional pro-coagulating factors. [[26]](/content/point-of-care/30111#ref_19110086 ""/index.html) This process is called atherosclerosis. The activation of platelets causes adhesion and aggregation, which leads to the formation of a clot. The occlusion of vessels due to atherosclerosis and thrombin formation in the coronary arteries of the heart leads to ischemic heart disease and myocardial infarction. A similar process can occur with ischemic stroke in the cerebral vessels, and ischemic strokes can result from both thrombosis of the cerebral arteries and emboli from the heart. [[27]](/content/point-of-care/30111#ref_35794095 ""/index.html)

Histopathology

Histopathology of arterial vessels that contain thrombosis shows an area of fibrin with numerous platelets and leukocytes. Older layers tend to have fewer leucocytes compared to newer areas. Red blood cells can also be present, and these lines are called lines of Zahn. In arterial histopathology, there is usually a fibrous cap atheroma, which can contain a lipid-rich necrotic core. [[26]](/content/point-of-care/30111#ref_19110086 ""/index.html) In the venous system following acute thrombosis formation, an extensive remodeling process occurs. Neutrophils and macrophages infiltrate the fibrin clot from within the lumen of the vessel over weeks leading to cytokine release and, eventually, fibroblast and collagen replacement of fibrin. This remodeling and fibrosis can result in diminished blood flow long after the acute thrombosis resolves.

History and Physical

The signs and symptoms of thrombosis vary depending on the presumed location and acuity. Patients with a DVT often present with isolated extremity swelling, pain, warmth, and erythema at the site of the blockage. The patient typically describes the pain associated with a DVT as “crampy” located in the affected extremity. There may be a decreased range of motion of the extremity, inability to ambulate, or radiation of pain (eg, into the groin for LE DVT extending to the femoral vein). Patients with acute PE may present with pleuritic chest pain, shortness of breath, fatigue, back pain, syncope, or even death in severe cases. [[28]](/content/point-of-care/30111#ref_26780738 ""/index.html) Signs include tachycardia, tachypnea, and fever, and may include oxygen desaturation.

Most commonly, arterial thrombosis results in cardiac or cerebrovascular compromise. Those with acute thrombosis in the coronary arteries of the heart will often report “crushing” left-sided chest pain or heaviness with radiation to the left arm or jaw. If thrombosis occurs in one of the cerebral arteries, symptoms may include acute onset of unilateral weakness, headache, confusion, vision changes, dysarthria, dysphagia, paresthesias, difficulty ambulating, or frank paralysis of one or more extremities.

Evaluation

The evaluation of patients with venous thrombosis differs from that of suspected arterial thrombosis. This section will focus briefly on the workup for suspected venous and arterial thrombosis.

When patients present to the emergency department with signs and symptoms suggestive of possible venous thrombosis, a well-validated scale known as the modified Wells' criteria is applied to help guide further diagnostic studies. For patients with a high Wells score, a serum D-dimer should be checked. The D-dimer is a fibrin degradation product that is present in the blood after fibrinolysis. Its elevation is very sensitive (though less specific) to detect venous thrombosis. It is important to note that D-dimer is also elevated in other conditions such as pregnancy, malignancy, post-surgery, and infection. A negative D-dimer result helps to rule out a clot and avoid unnecessary imaging studies or anticoagulation initiation. [[29]](/content/point-of-care/30111#ref_14507948 ""/index.html)

When there is a high pretest probability for pulmonary embolism (PE) or DVT, imaging studies should be completed immediately without regard to D-dimer levels. For PE, the recommended imaging studies are CT angiography or ventilation/perfusion imaging (V/Q scan).  The V/Q scan is sometimes preferred over CT angiography to avoid intravenous contrast in those with underlying renal impairment. [[30]](/content/point-of-care/30111#ref_30482764 ""/index.html) However, not all facilities have V/Q scanning capabilities or expertise in interpreting the results, so CT angiography is often used. Often, pulmonary emboli result from fragmentation of preexisting DVT. Hence, ultrasound of the lower and/or upper extremities is also often performed to evaluate for concurrent DVT. This is especially important if a provoking catheter-related thrombosis is suspected, as the catheter may require eventual removal.

Determining whether a blood clot classifies as provoked or unprovoked and whether it is the first or subsequent episode are critical aspects of the initial evaluation that can guide further workup and treatment. Clinicians should take a careful personal and family history to document any thrombosis history or pregnancy morbidity. A family history of VTE in a first-degree relative correlates more with hypercoagulability than does a known thrombophilia. [[16]](/content/point-of-care/30111#ref_26780744 ""/index.html) In general, hypercoagulability testing is only recommended if it would change treatment. For example, in the case of a provoked VTE, treatment is the same regardless of the presence or absence of a thrombophilia, so testing is not recommended. Patients with an unprovoked VTE have a 5-year risk of recurrence without treatment, so long-term anticoagulation is recommended barring contraindications—also regardless of thrombophilia status. In terms of assessing risks, patients without a history of VTE do not need testing when evaluating pregnancy risk or use of estrogen (such as in oral contraceptives or hormone replacement therapy). The exception to this is in women with a first-degree relative who have a history of VTE and are found to have thrombophilia. This situation may warrant VTE prophylaxis or the avoidance of exogenous estrogen. [[16]](/content/point-of-care/30111#ref_26780744 ""/index.html)

Hypercoaguability testing may include checking the amount of proteins C and S, antithrombin III, or mutational testing for factor V Leiden or prothrombin gene mutation. Acquired thrombophilia testing may also be indicated, such as antiphospholipid antibody testing, which includes lupus anticoagulant, IgG/IgM anticardiolipin, and anti-beta-2-glycoprotein I.

Acute thrombotic events can make testing for thrombophilia inaccurate due to consumption of coagulation factors, and anticoagulation therapy can also interfere with the interpretation of test results in the acute setting. It is recommended that hypercoagulability workup be postponed until 3 months after anticoagulation for the thrombotic event is discontinued. For antiphospholipid antibody testing, many medications (including several anticoagulants), as well as underlying connective tissue diseases such as SLE, can affect the testing results. When antiphospholipid antibody testing is indicated, the recommendation is that the tests be repeated 12 weeks apart. This testing is often performed in the outpatient setting after the acute phase of the thrombosis has resolved and under the guidance of a hematologist. [[16]](/content/point-of-care/30111#ref_26780744 ""/index.html)

Malignancy can be an underlying provoking factor for both venous and arterial thrombosis. In general, it is not recommended for patients to have an extensive malignancy workup aside from age-appropriate cancer screening (including a chest CT for patients who smoke) unless clinical symptoms suggest additional workup. In carefully selected patients, especially those over the age of 50 with seemingly unprovoked thrombosis, further evaluation to search for occult malignancy may be indicated. [[31]](/content/point-of-care/30111#ref_34889390 ""/index.html)

Arterial thrombosis is most commonly caused by atherosclerosis. Diagnostic imaging includes CT angiography or magnetic resonance angiography to image the vasculature of the affected organ. This will also reveal vascular abnormalities such as aneurysms, dissections, fibromuscular dysplasia, or other anatomic abnormalities. If an MI occurs, cardiac catheterization is usually performed. Uncommon causes of MI are illicit drug use or vasospastic angina (ie, Prinzmetal's angina). [[32]](/content/point-of-care/30111#ref_30197243 ""/index.html)

To image for cardioembolic sources (a common cause of CVA and the leading differential diagnosis cause of thromobosis), a detailed echocardiogram with a bubble study to evaluate for a patent foramen ovale is warranted. Telemetry to look for paroxysmal atrial fibrillation is often used. Medications and illicit drug use can also precipitate arterial thrombosis, so a detailed medication history and drug screen are useful. [[31]](/content/point-of-care/30111#ref_34889390 ""/index.html) [[32]](/content/point-of-care/30111#ref_30197243 ""/index.html)

Treatment of arterial thromboses is specific to the location of thrombus and underlying medical conditions. As previously noted, antiplatelet medications are generally indicated. Depending on other risk factors and prior use of antiplatelet therapy, treatment with an additional antiplatelet agent (such as a P2Y12 inhibitor) or with very low-dose anticoagulation may be warranted. DOACs are also being studied for use in arterial thrombi, however, with a known cardioembolic source, vitamin K antagonist therapy is still the recommended treatment. [[31]](/content/point-of-care/30111#ref_34889390 ""/index.html) [[33]](/content/point-of-care/30111#ref_30129979 ""/index.html)

Treatment / Management

The treatment of both arterial and venous thrombosis differs. Venous thromboembolism management encompasses the use of various anticoagulant agents that target procoagulant factors, while arterial thrombosis management is predominantly with antiplatelet agents as monotherapy or dual-antiplatelet therapy. There are many variations and combinations of these treatment options.

As noted, many of the specific scenarios on anticoagulation and antiplatelet therapy indications are beyond the scope of this review article. Subspecialty consultation with pulmonology, cardiology, neurology, and/or hematology may be necessary in special cases. Please refer to societal guidelines (ie, American Society of Chest Physicians, American Heart Association, and American Society of Hematology) for case- and disease-specific recommendations.

Regarding VTE, the American Society of Hematology established a 2018 update to their guidelines for managing venous thrombosis, including prophylaxis use in hospitalized patients. In general, venous thrombosis is categorized into provoked or unprovoked etiologies. Furthermore, one must determine if the thrombosis is a first episode or recurrent episode. A thorough personal and family history of VTE with careful assessment of provoking risk factors and comorbidities is essential. A  provoked VTE results from reversible, modifiable, or acquired risk factors (eg, recent surgery, trauma, infection, pregnancy, morbid obesity, oral contraceptive usage, prolonged immobility, heavy smoking, or underlying malignancy). Unprovoked thrombosis, on the other hand, occurs in the absence of any apparent provoking factor. The treatment of venous thrombosis entails three stages, the initial, chronic, and extended stages. [[34]](/content/point-of-care/30111#ref_27102510 ""/index.html) Treatment may vary depending on whether it is a first episode or recurrent episode, the extent of the thrombosis burden, whether provoking risk factors are transient or persistent, and whether symptoms resolve or remain chronic such as in post-thromobitic syndrome. [[35]](/content/point-of-care/30111#ref_33720757 ""/index.html)

Guidelines now suggest the use of direct oral anticoagulants (DOACs) over vitamin K antagonists (ie, warfarin) for most VTE conditions. The DOACs most commonly used are dabigatran, apixaban, edoxaban and rivaroxaban. Dabigatran is a direct thrombin inhibitor, while the other 3 medications are Factor Xa inhibitors. Previously, these medications were less commonly used due to an unknown safety profile and lack of reversal; but currently their safety profile is recognized, and reversal agents are available. [[36]](/content/point-of-care/30111#ref_36909153 ""/index.html) [[37]](/content/point-of-care/30111#ref_30730782 ""/index.html) Current recommendations strongly favor the use of DOACs in VTE based on increased efficacy, ease of monitoring, and fewer bleeding events. [[38]](/content/point-of-care/30111#ref_33007077 ""/index.html) [[39]](/content/point-of-care/30111#ref_34475602 ""/index.html) [[40]](/content/point-of-care/30111#ref_30482765 ""/index.html) DOACs are generally preferred for anticoagulation in cases of atrial fibrillation as well. The only strong indications for Vitamin K antagonists over DOACs are in valvular heart disease (including mechanical valves, mitral stenosis, or rheumatic heart disease) and anti-phospholipid syndrome where DOACs show worsened outcomes. [[17]](/content/point-of-care/30111#ref_33100166 ""/index.html) [[41]](/content/point-of-care/30111#ref_34773920 ""/index.html) The main barriers to increased DOAC are availability, cost, and renal clearance. [[36]](/content/point-of-care/30111#ref_36909153 ""/index.html) [(B3)](/content/point-of-care/30111# ""/index.html)

Management of acute DVT and PE in hospitalized patients typically includes anticoagulation with IV unfractionated heparin (UFH) or low molecular weight heparin with an eventual transition to oral anticoagulation. [[42]](/content/point-of-care/30111#ref_28762624 ""/index.html) After initiating heparin-based anticoagulants, warfarin or DOACs can then be added for chronic and extended management. For an initial provoked thrombosis, such as a simple distal DVT, the recommended duration is typically 3 months.  For the first episode of provoked thrombosis with extensive clot burden, massive PE associated with hemodynamic compromise, or in patients with multiple persistent provoking risk factors, a 3 to 6 month duration is warranted. In patients with recurrent DVT or PE, the duration of therapy becomes more complex, and the determination of significant provoking or transient risk factors is important for guiding treatment. Patients with active malignancy as a provoking risk factor for thrombosis should typically continue anticoagulation therapy for 6 months or longer. LMWH is preferred in those with malignancy-associated thrombosis for initial treatment, followed by the use of DOACs in patients without a significant bleeding risk and GFR>30. Caution must also be used in those with gastrointestinal malignancies. [[43]](/content/point-of-care/30111#ref_35772465 ""/index.html) [(A1)](/content/point-of-care/30111# ""/index.html)

Unfractionated heparin requires monitoring the partial thromboplastin time (PTT). LMWH does not require monitoring, although occasionally patients who are morbidly obese can be monitored by checking anti-Factor Xa levels. For vitamin K antagonists (eg, warfarin), the PT/INR should be monitored and maintained in the therapeutic range. With the DOACs, no routine blood monitoring is necessary; however, medication compliance/adherence remains paramount to assuring the efficacy of these medications. For patients with confirmed acute heparin-induced thrombocytopenia & thrombosis (HITT), a non-heparin anticoagulant—such as argatroban, bivalirudin, danaparoid, or fondaparinux—should be utilized, and expert consultation with hematology is the recommendation. Warfarin should be avoided acutely as there is a risk of skin necrosis in the setting of HITT. DOACs in this setting have not been extensively studied but may become a viable alternative. [[44]](/content/point-of-care/30111#ref_32195628 ""/index.html)

For inpatients, the American Society of Hematology (ASH) recommends that prophylactic-dose unfractionated heparin (UFH) or low molecular heparin (LMWH) should be used (with adjustment for renal impairment as indicated). If there is any contraindication to anticoagulation or high bleeding risk, mechanical prophylaxis of the lower extremities should be employed. Mechanical methods of prophylaxis include intermittent compression devices and graduated elastic compression stockings. [[45]](/content/point-of-care/30111#ref_30482763 ""/index.html) [(B3)](/content/point-of-care/30111# ""/index.html)

Apart from pharmacological management, endovascular treatment is also used in some facilities to manage thrombosis. It is reported to be more successful if the thrombus is truly acute (ie formation two weeks before the presentation). Different endovascular methods include catheter-directed thrombolysis, percutaneous aspiration thrombectomy, venous balloon dilatation, and pharmacomechanical catheter-directed thrombolysis. [[46]](/content/point-of-care/30111#ref_27664152 ""/index.html) The use of inferior vena cava (IVC) filters remains controversial and should only be considered in select cases. IVC filters carry their own risk of potential complications and can serve as a nidus for thrombus formation. In general, for acute DVT, the use of IVC filters should be avoided unless there is an absolute contraindication to anticoagulation or severe active bleeding. When used, a retrievable type of IVC filter is preferred, and anticoagulation should be offered as soon as safely feasible. A risk-benefit analysis of various options and informed patient decision-making is the key to the selection of these specialized intervention modalities, and subspecialty consultation is strongly advised. [(B3)](/content/point-of-care/30111# ""/index.html)

Differential Diagnosis

An embolism is the leading contender in the differential diagnosis of thrombosis. In the latter, a clot is formed in the affected location, causing the narrowing of vessels. In embolism, the clot travels from a primary site to a different location. For instance, in patients with DVT, the clot can get dislocated to the lungs ending up forming PE. Septic emboli should be considered in patients with a risk of systemic infection, IV drug abuse history, or those with suspected or confirmed bacterial endocarditis. Chronic peripheral vascular disease can lead to similar symptoms in the extremities, and patients should have vascular surgery evaluation if suspected.

Prognosis

The prognosis of thrombosis varies depending on the type of thrombosis (venous or arterial), the location of the thrombosis, the severity of thrombosis, the persistence of provoking risk factors and comorbidities, and whether it is the first or subsequent episode of thrombosis.  Patients with VTE are at a higher risk than the general population for recurrence, especially if they have underlying provoking risk factors. Up to 25% of patients who have experienced VTE may encounter recurrent VTE within 10 years. [[47]](/content/point-of-care/30111#ref_23178976 ""/index.html)  The risk of recurrence is higher among patients with multiple cumulative provoking risk factors or underlying confirmed hereditary or acquired thrombophilia. An estimated 300000 deaths occur per year due to venous thromboembolism in the European Union. [[48]](/content/point-of-care/30111#ref_17938798 ""/index.html) Cardiovascular disease remains the leading cause of mortality in the U.S., and in patients with cerebrovascular disease, mortality is as high as 20% within the first 30 days of sustaining an ischemic CVA; as many as 30% of survivors will be permanently disabled following a stroke. [[46]](/content/point-of-care/30111#ref_27664152 ""/index.html) Prevention of venous and arterial thrombosis is critical, and an understanding of lifestyle characteristics and modifiable risk factors should be conveyed to patients.

Complications

Thrombosis can give rise to complications if improperly managed during an initial presentation. One significant, well-studied complication is post-thrombotic syndrome, which is a complication of DVT. Reports are that about 20 to 50% of DVT patients will develop this condition within 1 to 2 years after presentation. [[49]](/content/point-of-care/30111#ref_18695373 ""/index.html) The risk factors for developing post-thrombotic syndrome are recurrent DVT at the same site, obesity, and poor compliance with anticoagulation. Patients usually present with chronic pain, heaviness, cramps, and swelling exacerbated during exercise and relieved with rest. [[42]](/content/point-of-care/30111#ref_28762624 ""/index.html) Studies have shown that the use of elastic compression stockings may help prevent this condition. [[50]](/content/point-of-care/30111#ref_9074574 ""/index.html)

Pulmonary hypertension is also another complication seen as a result of chronic thromboembolism in the pulmonary vasculature. Estimates are that 0.1 to 9% of patients with a history of PE develop pulmonary vascular disease. Unlike other types of pulmonary hypertension, chronic thromboembolic disease is curable by the removal of the clot in the vasculature. [[42]](/content/point-of-care/30111#ref_28762624 ""/index.html) This is called pulmonary endarterectomy.

Another major complication associated with thrombosis is spontaneous hemorrhage (both intracranial and extracranial) that can result from therapy with full-dose anticoagulation or antiplatelet agents.  Intracranial hemorrhage can have especially damaging long-term effects. There are reports that the mortality of intracranial hemorrhage could be as high as 50% in patients using vitamin K antagonists (ie, warfarin). [[51]](/content/point-of-care/30111#ref_23479259 ""/index.html) Patients treated with anticoagulation due to VTE have a risk of major bleeding of 7.2 events per 100 person-years, a risk of fatal bleeding of 1.31 per 100 person-years, and a case fatality rate of 13.4% due to major bleed. [[51]](/content/point-of-care/30111#ref_23479259 ""/index.html) Assessing the risk of bleeding from anticoagulant or antiplatelet agents is an essential clinical objective, and patients should receive counsel on this risk and avoidance of situations that could predispose to bleeding (such as contact sports). Patients at particularly high risk of bleeding complications include the elderly, those with uncontrolled hypertension, those taking antiplatelet agents alongside anticoagulation, and those on warfarin.

Deterrence and Patient Education

As noted, the causes of venous and arterial thrombosis are multifactorial, and context is important. Many acquired or modifiable risk factors can increase the likelihood of developing thrombosis. Patients should receive counseling regarding these risk factors and what they can do to ameliorate their risk. Patients who are known to have an underlying hypercoagulable state (eg, those taking estrogen, pregnant women, or morbidly obese patients) should be informed of their risk of thrombosis. Patients should be counseled to avoid long periods of immobility and to stretch often. The use of elastic compression stockings may be helpful. Smoking cessation should be reinforced. For patients on anticoagulant or antiplatelet therapy, it is prudent to conduct a review of the risks of major bleeding. Patients should be counseled on fall precautions while on these agents.

Enhancing Healthcare Team Outcomes

Primary physicians and other health professionals should help patients reduce their risk of thrombosis by providing accurate information on prevention and treatment. Both venous and arterial thrombosis share similar risk factors, and efforts should be made to educate and encourage patients to make healthy lifestyle choices. Patients with metabolic syndrome or uncontrolled blood pressure should receive education on the importance of lifestyle modification and when indicated, secondary prevention with medical management.

Patients admitted to the hospital are also at higher risk of thrombosis. The American Society of Hematology in 2018 recommended prophylaxis in patients admitted to hospital settings. Patients who do not get prophylaxis like unfractionated heparin UFH or LMWH, or mechanical prophylaxis are at high risk of developing thrombosis. Therefore, care is necessary when managing patients admitted to the hospital, and daily reassessment of the risk of thrombosis is recommended in these settings.

References

[1]

Mackman N. Triggers, targets and treatments for thrombosis. Nature. 2008 Feb 21:451(7181):914-8. doi: 10.1038/nature06797. Epub [PubMed PMID: 18288180]

[2]

del Zoppo GJ. Virchow's triad: the vascular basis of cerebral injury. Reviews in neurological diseases. 2008:5 Suppl 1(Suppl 1):S12-21 [PubMed PMID: 18645567]

Level 3 (low-level) evidence

[3]

Thapa B, Fazal S, Parsi M, Rogers HJ. Myeloproliferative Neoplasms. StatPearls. 2026 Jan:(): [PubMed PMID: 30285359]

[4]

Barbui T, De Stefano V, Falanga A, Finazzi G, Martinelli I, Rodeghiero F, Vannucchi AM, Barosi G. Addressing and proposing solutions for unmet clinical needs in the management of myeloproliferative neoplasm-associated thrombosis: A consensus-based position paper. Blood cancer journal. 2019 Aug 8:9(8):61. doi: 10.1038/s41408-019-0225-5. Epub 2019 Aug 8 [PubMed PMID: 31395856]

Level 3 (low-level) evidence

[5]

Prandoni P. Venous and Arterial Thrombosis: Is There a Link? Advances in experimental medicine and biology. 2017:906():273-283 [PubMed PMID: 27628000]

Level 3 (low-level) evidence

[6]

Ahmed S, Zimba O, Gasparyan AY. Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad. Clinical rheumatology. 2020 Sep:39(9):2529-2543. doi: 10.1007/s10067-020-05275-1. Epub 2020 Jul 11 [PubMed PMID: 32654082]

[7]

Lowe GD. Venous and arterial thrombosis: epidemiology and risk factors at various ages. Maturitas. 2004 Apr 15:47(4):259-63 [PubMed PMID: 15063477]

[8]

Favaloro EJ, Franchini M, Lippi G. Aging hemostasis: changes to laboratory markers of hemostasis as we age - a narrative review. Seminars in thrombosis and hemostasis. 2014 Sep:40(6):621-33. doi: 10.1055/s-0034-1384631. Epub 2014 Aug 6 [PubMed PMID: 25099191]

Level 3 (low-level) evidence

[9]

Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrøm J. Incidence and mortality of venous thrombosis: a population-based study. Journal of thrombosis and haemostasis : JTH. 2007 Apr:5(4):692-9 [PubMed PMID: 17367492]

[10]

Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism. Journal of thrombosis and thrombolysis. 2016 Jan:41(1):3-14. doi: 10.1007/s11239-015-1311-6. Epub [PubMed PMID: 26780736]

[11]

Liao S, Woulfe T, Hyder S, Merriman E, Simpson D, Chunilal S. Incidence of venous thromboembolism in different ethnic groups: a regional direct comparison study. Journal of thrombosis and haemostasis : JTH. 2014 Feb:12(2):214-9. doi: 10.1111/jth.12464. Epub [PubMed PMID: 24283769]

Level 2 (mid-level) evidence

[12]

Lee CH, Lin LJ, Cheng CL, Kao Yang YH, Chen JY, Tsai LM. Incidence and cumulative recurrence rates of venous thromboembolism in the Taiwanese population. Journal of thrombosis and haemostasis : JTH. 2010 Jul:8(7):1515-23. doi: 10.1111/j.1538-7836.2010.03873.x. Epub 2010 Mar 25 [PubMed PMID: 20345707]

Level 2 (mid-level) evidence

[13]

Kim AS, Khorana AA, McCrae KR. Mechanisms and biomarkers of cancer-associated thrombosis. Translational research : the journal of laboratory and clinical medicine. 2020 Nov:225():33-53. doi: 10.1016/j.trsl.2020.06.012. Epub 2020 Jul 6 [PubMed PMID: 32645431]

[14]

Goshua G, Bendapudi PK, Lee AI. Thrombosis questions from the inpatient wards. Hematology. American Society of Hematology. Education Program. 2022 Dec 9:2022(1):481-490. doi: 10.1182/hematology.2022000384. Epub [PubMed PMID: 36485139]

[15]

Roeder HJ, Lopez JR, Miller EC. Ischemic stroke and cerebral venous sinus thrombosis in pregnancy. Handbook of clinical neurology. 2020:172():3-31. doi: 10.1016/B978-0-444-64240-0.00001-5. Epub [PubMed PMID: 32768092]

[16]

Stevens SM, Woller SC, Bauer KA, Kasthuri R, Cushman M, Streiff M, Lim W, Douketis JD. Guidance for the evaluation and treatment of hereditary and acquired thrombophilia. Journal of thrombosis and thrombolysis. 2016 Jan:41(1):154-64. doi: 10.1007/s11239-015-1316-1. Epub [PubMed PMID: 26780744]

[17]

Cohen H, Cuadrado MJ, Erkan D, Duarte-Garcia A, Isenberg DA, Knight JS, Ortel TL, Rahman A, Salmon JE, Tektonidou MG, Williams DJ, Willis R, Woller SC, Andrade D. 16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends. Lupus. 2020 Oct:29(12):1571-1593. doi: 10.1177/0961203320950461. Epub [PubMed PMID: 33100166]

[18]

Mosevoll KA, Johansen S, Wendelbo Ø, Nepstad I, Bruserud Ø, Reikvam H. Cytokines, Adhesion Molecules, and Matrix Metalloproteases as Predisposing, Diagnostic, and Prognostic Factors in Venous Thrombosis. Frontiers in medicine. 2018:5():147. doi: 10.3389/fmed.2018.00147. Epub 2018 May 22 [PubMed PMID: 29872658]

[19]

Hanff TC, Mohareb AM, Giri J, Cohen JB, Chirinos JA. Thrombosis in COVID-19. American journal of hematology. 2020 Dec:95(12):1578-1589. doi: 10.1002/ajh.25982. Epub 2020 Sep 16 [PubMed PMID: 32857878]

[20]

Bekal S, Husari G, Okura M, Huang CA, Bukari MS. Thrombosis Development After mRNA COVID-19 Vaccine Administration: A Case Series. Cureus. 2023 Jul:15(7):e41371. doi: 10.7759/cureus.41371. Epub 2023 Jul 4 [PubMed PMID: 37546104]

Level 2 (mid-level) evidence

[21]

Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, Nigoghossian C, Ageno W, Madjid M, Guo Y, Tang LV, Hu Y, Giri J, Cushman M, Quéré I, Dimakakos EP, Gibson CM, Lippi G, Favaloro EJ, Fareed J, Caprini JA, Tafur AJ, Burton JR, Francese DP, Wang EY, Falanga A, McLintock C, Hunt BJ, Spyropoulos AC, Barnes GD, Eikelboom JW, Weinberg I, Schulman S, Carrier M, Piazza G, Beckman JA, Steg PG, Stone GW, Rosenkranz S, Goldhaber SZ, Parikh SA, Monreal M, Krumholz HM, Konstantinides SV, Weitz JI, Lip GYH, Global COVID-19 Thrombosis Collaborative Group, Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. Journal of the American College of Cardiology. 2020 Jun 16:75(23):2950-2973. doi: 10.1016/j.jacc.2020.04.031. Epub 2020 Apr 17 [PubMed PMID: 32311448]

[22]

Delrue M, Stépanian A, Voicu S, Nassarmadji K, Sène D, Bonnin P, Kevorkian JP, Sellier PO, Molina JM, Neuwirth M, Vodovar D, Mouly S, Mebazaa A, Mégarbane B, Siguret V. No VTE Recurrence After 1-Year Follow-Up of Hospitalized Patients With COVID-19 and a VTE Event: A Prospective Study. Chest. 2022 Jul:162(1):226-229. doi: 10.1016/j.chest.2022.03.043. Epub 2022 Apr 7 [PubMed PMID: 35398318]

[23]

Potpara T, Angiolillo DJ, Bikdeli B, Capodanno D, Cole O, Yataco AC, Dan GA, Harrison S, Iaccarino JM, Moores LK, Ntaios G, Lip GYH. Antithrombotic Therapy in Arterial Thrombosis and Thromboembolism in COVID-19: An American College of Chest Physicians Expert Panel Report. Chest. 2023 Dec:164(6):1531-1550. doi: 10.1016/j.chest.2023.06.032. Epub 2023 Jun 29 [PubMed PMID: 37392958]

[24]

Bilotta C, Perrone G, Adelfio V, Spatola GF, Uzzo ML, Argo A, Zerbo S. COVID-19 Vaccine-Related Thrombosis: A Systematic Review and Exploratory Analysis. Frontiers in immunology. 2021:12():729251. doi: 10.3389/fimmu.2021.729251. Epub 2021 Nov 29 [PubMed PMID: 34912330]

Level 1 (high-level) evidence

[25]

Franchini M, Liumbruno GM, Pezzo M. COVID-19 vaccine-associated immune thrombosis and thrombocytopenia (VITT): Diagnostic and therapeutic recommendations for a new syndrome. European journal of haematology. 2021 Aug:107(2):173-180. doi: 10.1111/ejh.13665. Epub 2021 Jun 9 [PubMed PMID: 33987882]

[26]

Insull W Jr. The pathology of atherosclerosis: plaque development and plaque responses to medical treatment. The American journal of medicine. 2009 Jan:122(1 Suppl):S3-S14. doi: 10.1016/j.amjmed.2008.10.013. Epub [PubMed PMID: 19110086]

[27]

Qin C, Yang S, Chu YH, Zhang H, Pang XW, Chen L, Zhou LQ, Chen M, Tian DS, Wang W. Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions. Signal transduction and targeted therapy. 2022 Jul 6:7(1):215. doi: 10.1038/s41392-022-01064-1. Epub 2022 Jul 6 [PubMed PMID: 35794095]

Level 2 (mid-level) evidence

[28]

Streiff MB, Agnelli G, Connors JM, Crowther M, Eichinger S, Lopes R, McBane RD, Moll S, Ansell J. Guidance for the treatment of deep vein thrombosis and pulmonary embolism. Journal of thrombosis and thrombolysis. 2016 Jan:41(1):32-67. doi: 10.1007/s11239-015-1317-0. Epub [PubMed PMID: 26780738]

[29]

Wells PS, Anderson DR, Rodger M, Forgie M, Kearon C, Dreyer J, Kovacs G, Mitchell M, Lewandowski B, Kovacs MJ. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. The New England journal of medicine. 2003 Sep 25:349(13):1227-35 [PubMed PMID: 14507948]

Level 1 (high-level) evidence

[30]

Lim W, Le Gal G, Bates SM, Righini M, Haramati LB, Lang E, Kline JA, Chasteen S, Snyder M, Patel P, Bhatt M, Patel P, Braun C, Begum H, Wiercioch W, Schünemann HJ, Mustafa RA. American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism. Blood advances. 2018 Nov 27:2(22):3226-3256. doi: 10.1182/bloodadvances.2018024828. Epub [PubMed PMID: 30482764]

Level 3 (low-level) evidence

[31]

May JE, Moll S. Unexplained arterial thrombosis: approach to diagnosis and treatment. Hematology. American Society of Hematology. Education Program. 2021 Dec 10:2021(1):76-84. doi: 10.1182/hematology.2021000235. Epub [PubMed PMID: 34889390]

[32]

Picard F, Sayah N, Spagnoli V, Adjedj J, Varenne O. Vasospastic angina: A literature review of current evidence. Archives of cardiovascular diseases. 2019 Jan:112(1):44-55. doi: 10.1016/j.acvd.2018.08.002. Epub 2018 Sep 7 [PubMed PMID: 30197243]

[33]

O'Donnell M, Shatzel JJ, Olson SR, Daughety MM, Nguyen KP, Hum J, DeLoughery TG. Arterial thrombosis in unusual sites: A practical review. European journal of haematology. 2018 Dec:101(6):728-736. doi: 10.1111/ejh.13165. Epub 2018 Oct 15 [PubMed PMID: 30129979]

[34]

Becattini C, Agnelli G. Treatment of Venous Thromboembolism With New Anticoagulant Agents. Journal of the American College of Cardiology. 2016 Apr 26:67(16):1941-55. doi: 10.1016/j.jacc.2016.01.072. Epub [PubMed PMID: 27102510]

[35]

Visonà A, Quere I, Mazzolai L, Amitrano M, Lugli M, Madaric J, Prandoni P, European Society of Vascular Medicine (ESVM). Post-thrombotic syndrome. VASA. Zeitschrift fur Gefasskrankheiten. 2021 Sep:50(5):331-340. doi: 10.1024/0301-1526/a000946. Epub 2021 Mar 15 [PubMed PMID: 33720757]

[36]

Zheng W, Dai X, Xu B, Tian W, Shi J. Discovery and development of Factor Xa inhibitors (2015-2022). Frontiers in pharmacology. 2023:14():1105880. doi: 10.3389/fphar.2023.1105880. Epub 2023 Feb 21 [PubMed PMID: 36909153]

[37]

Connolly SJ, Crowther M, Eikelboom JW, Gibson CM, Curnutte JT, Lawrence JH, Yue P, Bronson MD, Lu G, Conley PB, Verhamme P, Schmidt J, Middeldorp S, Cohen AT, Beyer-Westendorf J, Albaladejo P, Lopez-Sendon J, Demchuk AM, Pallin DJ, Concha M, Goodman S, Leeds J, Souza S, Siegal DM, Zotova E, Meeks B, Ahmad S, Nakamya J, Milling TJ Jr, ANNEXA-4 Investigators. Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors. The New England journal of medicine. 2019 Apr 4:380(14):1326-1335. doi: 10.1056/NEJMoa1814051. Epub 2019 Feb 7 [PubMed PMID: 30730782]

[38]

Ortel TL, Neumann I, Ageno W, Beyth R, Clark NP, Cuker A, Hutten BA, Jaff MR, Manja V, Schulman S, Thurston C, Vedantham S, Verhamme P, Witt DM, D Florez I, Izcovich A, Nieuwlaat R, Ross S, J Schünemann H, Wiercioch W, Zhang Y, Zhang Y. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood advances. 2020 Oct 13:4(19):4693-4738. doi: 10.1182/bloodadvances.2020001830. Epub [PubMed PMID: 33007077]

Level 3 (low-level) evidence

[39]

Neumann I, Schünemann HJ, Bero L, Cooke G, Magrini N, Moja L. Global access to affordable direct oral anticoagulants. Bulletin of the World Health Organization. 2021 Sep 1:99(9):653-660. doi: 10.2471/BLT.20.278473. Epub 2021 Jun 1 [PubMed PMID: 34475602]

[40]

Witt DM, Nieuwlaat R, Clark NP, Ansell J, Holbrook A, Skov J, Shehab N, Mock J, Myers T, Dentali F, Crowther MA, Agarwal A, Bhatt M, Khatib R, Riva JJ, Zhang Y, Guyatt G. American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy. Blood advances. 2018 Nov 27:2(22):3257-3291. doi: 10.1182/bloodadvances.2018024893. Epub [PubMed PMID: 30482765]

Level 3 (low-level) evidence

[41]

Chao TF, Joung B, Takahashi Y, Lim TW, Choi EK, Chan YH, Guo Y, Sriratanasathavorn C, Oh S, Okumura K, Lip GYH. 2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary. Thrombosis and haemostasis. 2022 Jan:122(1):20-47. doi: 10.1055/s-0041-1739411. Epub 2021 Nov 13 [PubMed PMID: 34773920]

Level 3 (low-level) evidence

[42]

Winter MP, Schernthaner GH, Lang IM. Chronic complications of venous thromboembolism. Journal of thrombosis and haemostasis : JTH. 2017 Aug:15(8):1531-1540. doi: 10.1111/jth.13741. Epub [PubMed PMID: 28762624]

[43]

Farge D, Frere C, Connors JM, Khorana AA, Kakkar A, Ay C, Muñoz A, Brenner B, Prata PH, Brilhante D, Antic D, Casais P, Guillermo Esposito MC, Ikezoe T, Abutalib SA, Meillon-García LA, Bounameaux H, Pabinger I, Douketis J, International Initiative on Thrombosis and Cancer (ITAC) advisory panel. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19. The Lancet. Oncology. 2022 Jul:23(7):e334-e347. doi: 10.1016/S1470-2045(22)00160-7. Epub [PubMed PMID: 35772465]

Level 1 (high-level) evidence

[44]

Hogan M, Berger JS. Heparin-induced thrombocytopenia (HIT): Review of incidence, diagnosis, and management. Vascular medicine (London, England). 2020 Apr:25(2):160-173. doi: 10.1177/1358863X19898253. Epub 2020 Mar 20 [PubMed PMID: 32195628]

[45]

Schünemann HJ, Cushman M, Burnett AE, Kahn SR, Beyer-Westendorf J, Spencer FA, Rezende SM, Zakai NA, Bauer KA, Dentali F, Lansing J, Balduzzi S, Darzi A, Morgano GP, Neumann I, Nieuwlaat R, Yepes-Nuñez JJ, Zhang Y, Wiercioch W. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood advances. 2018 Nov 27:2(22):3198-3225. doi: 10.1182/bloodadvances.2018022954. Epub [PubMed PMID: 30482763]

Level 3 (low-level) evidence

[46]

Goktay AY, Senturk C. Endovascular Treatment of Thrombosis and Embolism. Advances in experimental medicine and biology. 2017:906():195-213 [PubMed PMID: 27664152]

Level 3 (low-level) evidence

[47]

Reitter-Pfoertner S, Waldhoer T, Mayerhofer M, Eigenbauer E, Ay C, Mannhalter C, Kyrle PA, Pabinger I. The influence of thrombophilia on the long-term survival of patients with a history of venous thromboembolism. Thrombosis and haemostasis. 2013 Jan:109(1):79-84. doi: 10.1160/TH12-05-0361. Epub 2012 Nov 22 [PubMed PMID: 23178976]

Level 2 (mid-level) evidence

[48]

Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, Greer IA, Heit JA, Hutchinson JL, Kakkar AK, Mottier D, Oger E, Samama MM, Spannagl M, VTE Impact Assessment Group in Europe (VITAE). Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thrombosis and haemostasis. 2007 Oct:98(4):756-64 [PubMed PMID: 17938798]

[49]

Shbaklo H, Kahn SR. Long-term prognosis after deep venous thrombosis. Current opinion in hematology. 2008 Sep:15(5):494-8. doi: 10.1097/MOH.0b013e32830abde2. Epub [PubMed PMID: 18695373]

Level 3 (low-level) evidence

[50]

Brandjes DP, Büller HR, Heijboer H, Huisman MV, de Rijk M, Jagt H, ten Cate JW. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet (London, England). 1997 Mar 15:349(9054):759-62 [PubMed PMID: 9074574]

Level 1 (high-level) evidence

[51]

Shoeb M, Fang MC. Assessing bleeding risk in patients taking anticoagulants. Journal of thrombosis and thrombolysis. 2013 Apr:35(3):312-9. doi: 10.1007/s11239-013-0899-7. Epub [PubMed PMID: 23479259]

[52]

Hermann A, Krais J, Tremetsberger AM, Ristl R, Klaeger JP, Schoergenhofer C, Buchtele N, Nagler B, Schellongowski P, Robak O, Stommel AM, Staudinger T. Cannula-Associated Deep Vein Thrombosis After Extracorporeal Life Support: A Prospective Diagnostic Study. Journal of clinical medicine. 2025 Oct 14:14(20):. doi: 10.3390/jcm14207241. Epub 2025 Oct 14 [PubMed PMID: 41156110]

[53]

Hung KC, Weng HL, Hsu CW, Lai YC, Chen IW. Association between iron deficiency anemia and risk of venous thromboembolism: a multi-institutional retrospective study. Frontiers in nutrition. 2025:12():1660622. doi: 10.3389/fnut.2025.1660622. Epub 2025 Oct 20 [PubMed PMID: 41190143]

Level 2 (mid-level) evidence

[54]

Onsaker AL, Arntzen AY, Trégouët DA, Nøst TH, Tang W, Guan W, Jonasson C, Morange PE, Hindberg KD, Folsom AR, Hveem K, Morelli VM, Hansen JB. Histo-blood group ABO system transferase plasma levels and risk of future venous thromboembolism: the HUNT study. Blood. 2025 May 29:145(22):2656-2665. doi: 10.1182/blood.2024025923. Epub [PubMed PMID: 40009491]

[55]

Moderegger EL, Dräger S, Preuss SL, Vorobyev A, Terheyden P, Kridin K, Bieber K, Ludwig RJ, Kahle B, Curman P. Increased risk of deep vein thrombosis, pulmonary embolism, and all-cause mortality in chronic venous disorder: a large-scale retrospective cohort study. Frontiers in medicine. 2025:12():1683970. doi: 10.3389/fmed.2025.1683970. Epub 2025 Oct 8 [PubMed PMID: 41133149]

Level 2 (mid-level) evidence

[56]

Harry J, Bucciol R, Finnigan D, Hashem H, Araki A, Othman M. The incidence of venous thromboembolism by type of solid cancer worldwide: A systematic review. Cancer epidemiology. 2025 Apr:95():102764. doi: 10.1016/j.canep.2025.102764. Epub 2025 Feb 6 [PubMed PMID: 39919489]

Level 1 (high-level) evidence

[57]

Wan T, Song J, Zhu D. Cancer-associated venous thromboembolism: a comprehensive review. Thrombosis journal. 2025 Apr 16:23(1):35. doi: 10.1186/s12959-025-00719-7. Epub 2025 Apr 16 [PubMed PMID: 40241146]

[58]

Piazza G, Krishnathasan D, Hamade N, Ujueta F, Scimeca G, Ortiz-Rios MD, McGonagle B, Galanaud JP, Jiménez D, Monreal M, Fanikos J, Dua A, Tefera L, Kolluri R, Parikh SA, Ageno W, Goldhaber SZ, Weitz JI, Moores LK, Quéré I, Bikdeli B. Superficial Vein Thrombosis: A Review. JAMA. 2025 Dec 9:334(22):2020-2030. doi: 10.1001/jama.2025.15222. Epub [PubMed PMID: 40952730]

Copy link

✓

Thanks for sharing!

Find any service

AddToAny

[More…](/content/point-of-care/30111#addtoany "Show all"/index.html)

A2A

reCAPTCHA

Get aFree StatPearls Question-Of-The-Day

For Your Specialty.

Send IT